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Patient nonadherence to physicians’ prescribed therapeutic regimen is the greatest 
challenge in the effective treatment of patients with diabetes worldwide. Scientific 
evidence has revealed that nonadherence to prescribed medication could result in diabetic 
complications such as cardiovascular disease, retinopathy, nephropathy, and neuropathic 
diabetic foot ulcers. The purpose of this study was to explore predictive relationships 
between levels of adherence to antidiabetic medications, patient HbA1c levels, and 
diabetic complications among Jamaicans, an understudied population. The research 
question that guided this study was: Do the patient level of adherence and HbA1c levels 
have any predictive relationship with the severity of diabetic complications 
(cardiovascular disease, retinopathy, nephropathy and neuropathic foot ulcer) among 
Jamaicans after controlling for age and gender? The theory of planned behavior was used 
to guide the study. Data regarding diabetic complications were collected from 119 
records during a cross-sectional review of patient dockets. Level of adherence was 
determined from an interviewer-administered Morisky 8-item adherence scale. A 
multiple regression analysis revealed that lower levels of patient adherence to treatment 
and higher HbA1c levels predicted greater severity of cardiovascular disease (p = .000; p 
= .000), retinopathy (p = .009; p =.090), nephropathy (p =.007; p =.001) and diabetic 
neuropathic foot ulcers (p =.027; p =.001). Findings from this study will contribute to the 
knowledge base on diabetic medication nonadherence and may encourage health care 
professionals to advocate for better medication adherence strategies among people with 
diabetes.       
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Chapter 1: Introduction to the Study  
Introduction 
Health care providers expect individuals living with diabetes mellitus to have an 
adequate understanding of the nature of the disease and the treatment options available to 
treat the disease. These expectations include understanding the role of antidiabetic 
medications in maintaining glycemic control and the consequence of sustained, 
uncontrolled hyperglycemia. Individuals living with diabetes should adhere to 
physicians’ prescribed treatment regimens (Arifulla, John, Sreedharan, Muttappallymyalil 
& Basha, 2014). However, findings from studies have shown that many patients fail to 
adhere to treatment recommendations. Consequently, many people with diabetes face 
acute and chronic complications (Amado et al., 2015; Kumar, Abbas & Fausto, 2010). 
Amado et al. (2015) suggested that nonadherence to treatment compromises a patient’s 
ability to achieve optimal treatment. Khan et al. (2012) argued that there are many 
reasons why people with diabetes do not adhere to prescribed therapeutic regimens. 
These reasons include lack of adequate motivations to take prescribed medication, 
inability to adapt to the lifestyle and behavioral changes essential to maintain glycemic 
control, and lack of understanding of the severity of diabetic complications. It is also true 
that some patients become nonadherent because they are unable to keep appointments 
with both the primary and specialist physicians (Khan et al., 2015). Arifulla et al. (2014) 
concluded that forgetfulness is one of the most common reasons for nonadherence to 
antidiabetic medication. Other researchers have identified factors such as side effects of 
antidiabetic medication, treatment regimen complexities, as well as sociodemographic 
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status as major factors that influence patient adherence to medication (Arifulla, et al., 
2014; Kassahun, Gashe, Mulisa & Rike, 2016). Low adherence translates to uncontrolled 
diabetes mellitus which is problematic because it compromises the immune system and 
promotes a number of complications such as retinopathy, nephropathy, cardiovascular 
diseases, and diabetic neuropathic foot ulcers (Kaul, Ahmad, Tarr, Kohner & Chibber, 
2013).   
 In this chapter, I will summarize empirical literature that forms the background of 
this study. I will also present the problem statement, the purpose of this study and the 
research questions. In addition, I will define key terms, discuss the assumptions, scope of 
the study, delimitations, limitations, and significance of this study.  
Background  
Diabetes mellitus (DM) has been defined as a metabolic syndrome that targets 
multiple organs (Kumar, Abbas & Fausto, 2010). Kaul et al. (2013) suggested that 
diabetes mellitus is a chronic debilitating metabolic disease that has tremendous health, 
social, and economic consequences. Papadakis and McPhee (2015) argued that DM is a 
metabolic syndrome that is characterized by inappropriate hyperglycemia which occurs 
when the pancreatic islet cells malfunction. The dysfunctions of the pancreatic islet cells 
translate to deficiencies of insulin secretion or insulin resistance or both (Papadakis & 
McPhee, 2010). As a result, doctors make recommendations for prescriptions drugs that 
target and correct the metabolic abnormalities to prevent diabetic complications 
(Papadakis & McPhee, 2015).  
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According to Khadar et al. (2015) Type 2 DM is characterized by a combination 
of multiple pathologies which includes insulin resistance, insufficient insulin secretion, 
and inappropriate glucagon secretion. These complex abnormalities manifest as an array 
of metabolic dysfunctions that are characterized by hyperglycemia, high levels of free 
fatty acids, elevated levels of pro-inflammatory cytokines in plasma, decreased glucose 
transport into muscle cells, increased breakdown of fat, and elevated hepatic 
gluconeogenesis. All these metabolic abnormalities are common in both Type 1 and Type 
2 DM (Khardori et al., 2015). Kumar, Abbas, and Fausto (2010) explicated that DM is 
more than a disease; rather, it is a group of coordinated metabolic disorders that share a 
common denominator which is hyperglycemia. Uncontrolled sustained hyperglycemia 
may have profound consequences that may include damage to major organs and 
metabolic dysregulations (Kumar et al.,2010).  
According to the American Diabetes Association (2014) insulin synthesis, 
secretion, and sensitivity are key to glycemic control; an interruption in any part of the 
insulin process could evolve into Type 2 DM. Most common diabetic complications are 
due to insulin dysregulations and those complications include diabetic retinopathy, 
nephropathy, cardiovascular disease, and diabetic neuropathic foot ulcers (Kumar et al., 
2010). Medical authorities agree that patient adherence to medical treatment of diabetes 
prevents debilitating diabetic complications (Kumar et al., 2010; Arifulla et al., 2014). 
Medication adherence is defined as the degree to which a person with diabetes patient 
takes prescribed medication as recommended by the attending physician or health care 
provider (Arifulla et al., 2014).  
4 
 
The World Health Organization (WHO) survey on the global prevalence of DM 
revealed that the global burden of diabetes was at an all-time high in 2012 (WHO, 2014). 
Findings from the survey revealed that the worldwide prevalence of DM in 2012 was 
about 9% among individuals from 18 years of age and above (WHO, 2015). The data also 
showed that about 1.5 million deaths worldwide were directly related to diabetes in 2012 
(WHO, 2015). Diabetes mellitus was projected by the WHO to be the seventh leading 
cause of death worldwide by the year 2030 (WHO, 2015). The WHO also reported that 
approximately 80% of diabetes-related deaths occur among individuals who are in low 
and middle socioeconomic levels (WHO, 2015).  
The International Diabetic Federation (IDF) suggested that the number of 
individuals with DM may rise from about 366 million individuals in 2011 to about 552 
million people by the year 2030. The IDF also indicated that about 183 million 
individuals worldwide who are currently living with diabetes may be unaware of their 
status (Lysenko & Laakso, 2013). According to Hirst (2013) about 5.1 million deaths 
worldwide were directly attributed to diabetes mellitus in 2013, with a financial burden 
estimated at $548 billion in the same year worldwide.  
The Center for Disease Control and Prevention (CDC) reported that in the United 
States about 29.1 million (9.3%) people have diabetes in 2013(CDC, 2016). The 
prevalence of DM is higher among some racial/ethnic groups than others; American 
Indians and Alaskan Natives (16.1%) have the highest prevalence of diabetes mellitus 
followed by non-Hispanic Blacks (12.6%). The group that is least affected by diabetes is 
non-Hispanic White 7.1%; (American Diabetes Association, 2016). 
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Comparatively, the prevalence of DM among Jamaicans is as high as the 
prevalence in the United States and the rest of the world (Ferguson, Tulloch-Reid & 
Wilks, 2010). The prevalence rates of DM in Jamaica vary according to variables such as 
age and gender. The prevalence of diabetes mellitus in Jamaica among individuals 15–24 
years of age is 1.2% while it is 29.6% among older people aged 65–74 years. Ferguson et 
al. (2010) indicated that the prevalence of diabetes mellitus among individuals with 
normal BMI is 4% while it is approximately 13% among individuals who are obese. 
Ferguson et al. (2010) which is the most current published study on DM in Jamaica also 
indicated that approximately 9.3% of women have diabetes mellitus as compared to 6.4% 
of men in Jamaica. A total of 2.8% Jamaicans had impaired fasting glucose which is also 
known as prediabetes during 2007/2008 survey.  
According to Aschner et al. (2016) appropriate medical intervention during the 
prediabetes period could delay the onset of diabetes. Early diagnosis coupled with 
adequate intervention and adherence to medical treatment could further prevent the 
development of diabetic complications. Also, data from the United Kingdom Prospective 
Diabetes Study (UKPDS) showed that tight glucose control as evidenced by normal 
HbA1C levels decreased the incidence of diabetic complications. The UKPDS results 
also showed that after the onset of diabetes, there was a continuous decline in the number 
of the beta-cells functioning irrespective of the intervention method deployed by an 
attending physician (UKPDS, 2015). The viability of the beta cells and their functionality 
continued to regress as patients advanced in age and the number of years after diagnosis 
increased. Antidiabetic medications are given to help maintain optimal glycemic control 
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in presence beta cell decline and dysfunction. However, when a patient fails to adhere to 
the established treatment guidelines, it makes tight glycemic control difficult to achieve 
(Papadakis et al., 2015). The American Diabetes Association (ADA) recommends several 
guidelines regarding the treatment and management of diabetic complications. ADA 
recommends that HbA1c should be controlled at 7.0% or lower. Reducing HbA1C levels 
7.0% or less significantly reduces incidences of diabetic complications. After the onset of 
diabetes, the optimal HbA1C levels can only be achieved through patient adherence to 
medical treatment regimens. Optimal HbA1C levels can only be achieved after the onset 
of diabetes through treatment adherence (ADA, 2016). If a patient fails to adhere to 
prescribed treatment or if a physician fails to adhere to recommended standards of care as 
outlined by the ADA, diabetic complications for patients become eminent. In the case of 
Type 1 DM, the beta cells are nonexistent from onset. In Type 2 DM, the beta cells will 
continue to regress numerically and functionally as diabetes progresses with or without 
treatment, hence making treatment adjustments and adhering to prescribed treatment the 
key to preventing diabetic complications (ADA, 2016). Kumar et al. (2010) postulated 
that irrespective of the fact that there are disparities in the pathophysiology and 
pathogenesis of various forms of diabetes, most of the complications (microvascular, 
macrovascular, and neuropathic) accelerate due to nonadherence to antidiabetic 
medications. Khardori et al. (2015) further suggested that regardless of the type of 
diabetes, hyperglycemia appeared to be the determinant of microvascular and metabolic 
complications. Hence medication adherence that prevents hyperglycemia is effective in 
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decreasing the incidence of diabetic complications and even in enervating the severity of 
existing complications (Dunn, 2016). Taskaya (2015) suggested that, 
in diabetes management, providing glycemic control plays a main role in care and 
achieving it depends on the patient adherence to medical treatment faithfully. 
Therefore, adherence is the extent to which the patient’s medication taking 
behavior corresponded with the prescribed medication regimen (p. 602).  
Studies have shown that nonadherence to treatment among people with diabetes 
prevails across age groups; even young individuals with Type 1 diabetes experience 
challenges in adhering to recommended treatment regimens (Costa et al., 2015; Cox & 
Hunt, 2015). Kivimaki et al. (2013) suggested that there is substantial reduction in 
adherence to medication after individuals enter retirement age; change in socioeconomic 
status and comorbidities may contribute to the reduction in adherence level among this 
group. Khardori, et al. (2015) elucidated that the microvascular and macrovascular 
diabetic complications include cardiovascular disease, diabetic retinopathy (DR), diabetic 
nephropathy (DN), and diabetic neuropathic foot ulcer.  
Diabetic retinopathy (DR) 
DR is defined as a major complication of DM that manifests when the blood 
vessels in the retina are damaged and the blood vessels start leaking blood and other 
fluids into the retina (American Optometric Association [AOA], 2017). The progressive 
leak of blood and fluid into the retina causes the retinal tissues to swell, and if left 
untreated, diabetic retinopathy could cause blindness. Indications of DR include blurred 
8 
 
vision, seeing a dark spot in the center of vision, difficulty seeing well at night, and 
seeing spots or floaters (AOA, 2017)  
According to Khaw, Shah, and Elkington (2010), DR may present as gradual 
onset of visual loss which is an indication of long duration of uncontrolled 
hyperglycemia. Diabetic retinopathy (DR) may be classified as mild, moderate, 
proliferative, or nonproliferative (Bhavsar & Khardori, 2016). Nonproliferative diabetic 
retinopathy is characterized by micro aneurysm, dot hemorrhage and hard yellow 
exudates with well-defined edges (Khaw et al., 2010). Macula edema is usually present 
and may lead to diminished visual acuity. Diabetic maculopathy, also known as diabetic 
retinopathy at the macula, is the leading cause of blindness in patients with Type 2 
diabetes mellitus. The proliferative DR is epitomized by the presence of new blood 
vessels on the retina that seem to proliferate into the vitreous cavity (Khaw et al., 2010). 
The new blood vessels are highly susceptible to bleeding, thus resulting in a sudden 
decrease in vision and production of contractile membranes. The contractile membranes 
gradually detach the retina which leads to blindness. In some cases, the hemorrhage may 
lead to occlusion of the drainage angle of the anterior chamber causing rubeotic 
glaucoma (Khaw et al.., 2010).  
Diabetic nephropathy (DN) 
Diabetic nephropathy (DN) is a complication that has been diagnosed in 
individuals living with either Type 1 or Type 2 diabetes mellitus (DM) and typically 
starts manifesting about 10 to 15 years following onset of DM (Kumar et al., 2010). The 
pathology of DN is typified by distinct histologic changes that usually occur in the 
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glomeruli. Findings from studies have shown that diabetic nephropathy is the leading 
cause of end stage renal disease (Batuman & Khardori, 2016; Kumar et al., 2010). 
Chronic hyperglycemia coupled with hemodynamic crisis have been identified as triggers 
of diabetic nephropathy (Batuman & Khardori, 2016). Findings from research have 
revealed that accumulation of glucose and other metabolites work in synergy with 
increased vascular permeability to exacerbate extracellular matrix accumulation and 
proteinuria observed in diabetic nephropathy (Batuman & Khardori, 2016). 
Cardiovascular disease 
Cardiovascular disease is defined as a syndrome of heart conditions that affect the 
structure and function of the heart due to persistent hyperglycemia, hyperlipidemia, and 
elevated levels of amino acids (Fontes-Carvalho, Ladeiras-Lopes, Bettencourt, Leite-
Moreira & Azevedo, 2016). Common forms of cardiovascular diseases that are associated 
with DM include ischemic heart disease, heart failure, and stroke. Acceleration of the 
atherosclerosis of the aorta, medium size, and larger size arteries is the hallmark of DM. 
A major complication of atherosclerosis is myocardial infarction (MI) that is localized at 
the coronary arteries (Kumar et al., 2010). Hyaline arteriolosclerosis, a vascular lesion 
that is also associated with hypertension is more common and more devastating among 
people living with diabetes mellitus. Diabetic microangiopathy is another form of 
cardiovascular disease common among diabetics. The pathology involves diffuse 
thickening of various basement membranes and selective thickening of the capillaries of 
the renal medulla, renal glomeruli, retina, skeletal muscles, and the skin. The thickening 
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of the capillaries is directly responsible for the extensive leaky nature of the cardiac 
capillaries (Kumar et al. 2010).  
Diabetic Neuropathy and Foot Ulcers  
Diabetic neuropathy is the most common complication of diabetes mellitus, with 
about 50% of older patients with Type 2 DM affected (Papadakis et al., 2015). Diabetic 
neuropathy is classified as peripheral neuropathy (distal symmetric polyneuropathy and 
isolated peripheral neuropathy) or autonomic neuropathy (Kumar et al., 2010; Papadakis 
et al., 2015). Other types of diabetic neuropathy include proximal neuropathy and focal 
neuropathy (WebMD, 2017). The peripheral diabetic neuropathy affects the legs, feet and 
in some very rare cases affects the arms, abdomen and the back. When peripheral diabetic 
neuropathy manifests as a distal symmetric polyneuropathy the patient may experience 
loss of function that appear in a stocking-glove pattern due to an axonal neuropathic 
process. The axonal neuropathic process involves loss of long nerves that results in motor 
and sensory conduction delay in peripheral nerve and even absence of ankle jerks 
(Papadakis et al., 2015).  
Sensory involvement usually occurs first and is in general bilateral, symmetric 
and associated with dulled perception of vibration, pain and temperature the 
denervation of the small muscles of the foot results in clawing of the toes and 
displacement of fat pad (Papadakis et al., 2015, p.1215).  
The complex changes that occur in the foot because of diabetic neuropathy result 
in the alteration of the foot biomechanics. Extensive biomechanical variations in the foot 
promotes high pressure areas that rupture and become ulcerated, and such areas have 
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been implicated in most diabetic foot deformities (WebMD, 2017). Diabetic neuropathic 
foot ulcer consists of wounds that occurs because of compromised vasculatures due to 
poor perfusion. Diabetic neuropathic foot ulcers can be triggered by injury and/or 
infections in the high-pressure areas (Papadakis et al., 2015). Kumar et al. (2010) 
indicates that the pathogenesis of diabetic foot ulcer is typified by inadequate circulation 
to the lower extremities coupled with microvascular disease, in association with 
diminished sensation due to neuropathy. Infections of diabetic foot ulcer are major 
triggers of a span of broad spectrum of complication pathology ranging from superficial 
cellulitis to osteomyelitis. 
Diabetes mellitus is a complex metabolic syndrome that could trigger several 
types of complications such as diabetic retinopathy (DR), diabetic nephropathy (DN), 
cardiovascular disease and diabetic neuropathic foot ulcers. However, when patients and 
attending physicians adhere to recommended standards of care for diabetes, the risk of 
these complications for individuals declines to a bearable minimum (ADA, 2016). On the 
other hand, patient nonadherence to diabetic treatment exacerbates the excruciating 
problems that are linked to diabetes (ADA, 2016).  
Problem Statement 
According to Amado et al. (2015) nonadherence to physician- recommended 
therapeutics among people with diabetes is a global problem that deserves more attention. 
Kivimäki et al. (2013) argued that while antidiabetic medications have been shown to be 
effective in decreasing diabetic complications, patient nonadherence to taking medication 
is common, and the resultant diabetic complications are on the rise. Contreras et al. 
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(2011) reported that 25% of people with diabetes who participated in their study were 
therapeutically nonadherent. Amado et al. (2015) suggested that nonadherence to 
treatment plan compromises patient’s opportunity to achieve optimal glycemic control. 
Khan et al. (2012) argue that when the health seeking behaviors of a people with diabetes 
lack congruence with recommendations of a health care provider, the result is usually 
diabetic complications.  
Jamaica has a high prevalence of Type 1 and Type 2 diabetes mellitus (DM). 
According to the 2007/8 Jamaica Health and Life Style (JHLS) Survey, 7.9% of the 
population of Jamaica had DM and additional 2.8% of the population was living with 
impaired fasting glucose. Ferguson, Tulloch-Reid, and Wilks (2010) stated that there are 
only few published studies regarding adherence to diabetic medication treatment plans 
and diabetic complications in Jamaica and the Caribbean region. As a result, there is a 
gap in the literature regarding the relationships between levels of adherence to medical 
treatment and complications from diabetes in Jamaica.  
Purpose of Study 
In this quantitative, correlational study, I explored the relationship between levels 
of adherence to antidiabetic medications, HbA1c levels and diabetic complications 
(cardiovascular disease, diabetic retinopathy, diabetic nephropathy, diabetic neuropathic 
foot ulcer). This study revealed that levels of adherence to antidiabetic medication 
negatively correlates with diabetic complications while HbA1c levels positively 
correlates with diabetic complications. The outcome of this study may be key to creating 
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needed awareness and possibly encourage other researchers to help conduct more 
extensive study in this area.  
Research Questions and Hypotheses 
I examined the predictive relationships between patient level of adherence to 
therapeutic regimens (physician prescribed diabetic medication), HbA1c levels and 
diabetic complications. Levels of adherence to treatment and HbA1c were the 
independent variable while diabetic complications such as cardiovascular disease, 
retinopathy, nephropathy and neuropathic foot ulcer are the dependent variables. The 
control variables include age and gender. 
Research Question 1 (RQ1): How well do patient adherence to antidiabetic 
medication and HbA1c levels (glycemic control) predict the severity of retinopathy 
among people with diabetes in Jamaica after controlling for age and gender? 
Null Hypothesis (H01): Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels (glycemic control) are not statistically 
significant predictors of the severity of retinopathy among people with diabetes in 
Jamaica, after controlling for age and gender.  
Alternative Hypothesis (Ha1): Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of retinopathy among diabetic patients in Jamaica, after 
controlling for age and gender. 
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Research Question 2 (RQ2): How well do patient adherence to antidiabetic 
medication and HbA1c levels (glycemic control) predict the severity of nephropathy 
among people with diabetes in Jamaica, after controlling for age and gender?  
Null Hypothesis (H02): Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
severity of nephropathy among people with diabetes in Jamaica, after controlling for age 
and gender.  
Alternative Hypothesis (Ha2): Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of nephropathy among people with diabetes patients in Jamaica, 
after controlling for age and gender. 
Research Question 3 (RQ3): How well do patient adherence to antidiabetic 
medication and HbA1c levels predict the severity of cardiovascular disease among people 
with diabetes in Jamaica, after controlling for age and gender?  
Null Hypothesis (H03): Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
severity of cardiovascular disease among people with diabetes in Jamaica, after 
controlling for age and gender.  
Alternative Hypothesis (Ha3): Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of cardiovascular disease among people with diabetes patients 
in Jamaica, after controlling for age and gender. 
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Research Question 4 (RQ4): How well do patient adherence to antidiabetic 
medication and HbA1c levels predict the severity of neuropathic foot ulcer among people 
with diabetes in Jamaica, after controlling for age and gender?  
Null Hypothesis (H04): Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
severity of neuropathic foot ulcer among people with diabetes patients in Jamaica, after 
controlling for age and gender.  
Alternative Hypothesis (Ha4): Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of neuropathic foot ulcer among people with diabetes patients in 
Jamaica, after controlling for age and gender.  
The independent variables in this study were levels of adherence to recommended 
Antidiabetic medications determined by responses from Morisky 8-item Adherence Scale 
and HbA1C levels. The dependent variables were cardiovascular disease, retinopathy, 
nephropathy, and diabetic neuropathic foot ulcers.  
Theoretical framework 
Nonadherence to prescribed treatment could be viewed as a cognitive self-
regulated behavior that could be predicted in accordance to the theory of planned 
behavior (Janzen, 1985). The theory of planned behavior was proposed by Icek Ajzen in 
1985 in an article captioned "From intentions to actions: the theory of planned behavior" 
(Ajzen, 1985). The theory is an extension of the theory of the reasoned action which 
addresses the challenges of incomplete volitional control (Van Camp, Bastiaens, Van 
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Royen, & Vermeire, 2016). The theory of planned behavior suggests that human behavior 
is guided by the following three conceptual elements: (a) beliefs about the likely 
consequences of behavior (behavioral beliefs), (b) normative beliefs or the notion that 
expectations of other people influence a person’s behaviors and (c) volitional control, or 
beliefs which indicate that an individual can decide at will to perform or not perform a 
behavior (Ajzen, 1985). The fundamental principle of planned behavior theory is that 
behavioral beliefs or attitudes towards treatment plan translate into a healthy or unhealthy 
behavior, and that such behavior is predictable (Ajzen, 1985).  
The theory of planned behavior explicates that behavioral intentions is a major 
determinant of behavior because people seem to consider the implications of their actions 
before engaging or refraining in diverse kinds of behaviors. A person’s intentions, 
coupled with perceptions of behavioral control contribute to variance in actual behavior 
(Sharma & Romas, 2012). Sharma and Romas (2012) posited that past behaviors could 
be used to make prediction about future behavior. Findings from several studies have 
shown that the theory of planned behavior has been quite useful in making predictions 
about future behaviors (Sharma & Romas, 2012).  
Nature of Study 
In this quantitative, correlational study, I examined the predictive relationships 
between levels of adherence to antidiabetic medication, HbA1c and diabetic 
complications among diabetics in Jamaica. I used the cross-sectional design for this 
study. The cross-sectional design is one of the most commonly used research designs in 
health promotion and hence the most appropriate design for this study. In cross-sectional 
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design the data are usually collected at one point hence the time is fixed, and therefore it 
is considered the hallmark of this study design (Creswell, 2014).  
Definitions 
Definitions are presented to clarify terms used in this study and to assist readers to 
understand why such terms were use; these terms are listed below.  
Diabetes Mellitus: Khardori et al. (2015) defined diabetes mellitus as a chronic 
metabolic disorder characterized by a combination of insulin resistance at the peripheral 
level and inadequate insulin secretion by the beta cells in the pancreas or absence of 
insulin caused by autoimmune destruction of the beta cells.  
Medication adherence: Hugtenburg et al. (2013) defines medication adherence as 
the degree to which an individual is able conform to a physician’s prescribed treatment 
regimens (80% -100%).  
Medication nonadherence: Medication nonadherence is a diagnosable and 
treatable medical condition that could deprive a patient the opportunity to recover or the 
ability to mitigate the complications of disease (Marcum et al., 2013). Nonadherence is 
determined when a patient takes medication less than 80% of the recommendation. 
Diabetic retinopathy (DR): Diabetic retinopathy (DR) is defined as a major  
complication of inadequately controlled diabetes mellitus that manifests when the blood 
vessels in the retina are damaged (Kapadakis, 2015).  
Diabetic nephropathy (DN): Diabetic nephropathy is a complication that is 
characterized by persistent microalbuminuria, progressive decline in glomerular filtration 
rate (GFR) and elevated arterial blood pressure (Kumar, Abbas & Fausto, 2010). 
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Cardiovascular disease: Cardiovascular disease is defined as a syndrome of heart 
conditions that affect both the structure and function of the heart due to persistent 
hyperglycemia, hyperlipidemia and elevated levels of amino acids (Fontes-Carvalho, 
Ladeiras-Lopes, Bettencourt, Leite-Moreira & Azevedo, 2016).  
Diabetic neuropathic foot ulcer:. Diabetic neuropathic foot ulcers are wounds that 
occur because of compromised vasculatures that results into inadequate perfusion via the 
microcirculatory network (Kumar, Abbas & Fausto, 2010). 
Assumptions 
There are several assumptions associated with this research. It was my assumption 
that the archived data, the information and the variables in the database were complete, 
accurate and that the hospital collected them using interviewer administered Morisky 8-
item Adherence Scale and laboratory results of HbA1c of all the participants. It was my 
assumption that the respondents were honest and that inability to recall frequency of 
nonadherence did not affect the overall data. I assumed that other factors such as physical 
inactivity, diet, genetics and socioeconomic status do not contribute to the development 
of diabetic complications. I assumed normal distribution of the dependent (y) variable 
which are the diabetic complications and that there was linear relationship between x 
(independent variable) and y (dependent variable). I also assumed independent 
observations and homoscedasticity of the data collected (Grove & Cipher, 2017).  
Scope and Delimitations of Study 
I examined predictive relationship between patient adherence to antidiabetic 
medications and diabetic complications. Adherence to antidiabetic medication 
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determined by HbA1c levels and patient responses from Morisky-8 scale were the 
independent variables. The dependent variables were the following diabetic 
complications: cardiovascular disease, retinopathy, nephropathy and diabetic neuropathic 
foot ulcer. Age and gender were the control variables. It was beyond the scope of this 
study to address other mitigating factors that may contribute to the onset or prognosis of 
diabetic complications. In addition, diabetic complications such as diabetic ketoacidosis, 
hyperosmolar hyperglycemic state, diabetic enteropathy, diabetic peripheral neuropathy 
are the delimitations of this study.  
Limitations of Study 
A major limitation of this study was that there are many other factors such as 
sedentary lifestyle, smoking cigarettes, obesogenic diet options, advanced age, late or un-
diagnosed diabetes mellitus, use of complementary or alternative medicines and even co-
morbidities that could contribute to the manifestations of diabetic complications (Gemeay 
et al., 2015). The afore mentioned variables could also exacerbate the diabetic 
complications (Papadiski, 2015).  
Another limitation was that I used secondary data which might not be a true 
representation of the Jamaican society. The sample size used for this study was 119 and 
could be a constraint on the generalizability of this study. Responses to the Morisky 8-
item Adherence Scale questionnaire were self-reported and subjected to selective 
memory, telescoping, attribution and/or exaggeration (Brutus et al., 2012). Lack of prior 
studies on this topic in the Caribbean in recent years to reference as empirical data was 
also a limitation to this study.  
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Significance of Study 
Ferguson et al. (2010) indicated that a study on nonadherence to therapeutic 
regimens among Jamaican diabetics has never been done, and only very few studies of 
this nature have been conducted in Jamaica. Ferguson et al. (2010) also indicated that 
there are only few published data regarding diabetic complications in Jamaica and 
Caribbean region. The authors argue that such data will be helpful in planning effective 
strategies to combat diabetes mellitus. Hence it is essential to know whether the diabetic 
complications that are diagnosed among this population correlates with nonadherence to 
the recommended therapeutics. The potential positive social change impact of this study 
will be to inform other public health professionals to create public awareness about the 
consequences of patient nonadherence to medical treatment for diabetes.  
The information from this study would provide empirical evidence of the link 
between patient adherence or nonadherence to diabetic medication and diabetic 
complications among Jamaicans diagnosed with diabetes. Social workers and other health 
care professionals could use the information to advocate for specific interventions that 
focus on improving patient adherence to prescribed medications. Those interventions 
would then be a major step toward combating the epidemic of diabetic complications. An 
additional social change outcome would be improving the health outcomes for diabetic 
patients in Jamaica.  
Summary  
Diabetes mellitus is a chronic metabolic disorder that has become a global 
epidemic that leads to serious health implications (Shivashankar et al., 2016). The 2014 
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National Diabetes Statistics report indicates that 29.1 million individuals or 9.3 percent of 
American population is living with diabetes mellitus while only 21 million people are 
diagnosed with the disease, and 8.1 million undiagnosed (CDC, 2016). The burden of 
diabetes in many societies including Jamaica is great, but results of many studies have 
shown that adherence to recommended treatment has been effective in slowing down the 
progress of the disease and preventing diabetic complications (ADA, 2016).  
Diabetes treatment demands active involvement of the patients. However, 
nonadherence to physicians prescribed therapeutic regimen is the greatest challenge in 
the effective treatment of diabetic patients worldwide and has become a growing concern 
for all health care providers (Remington et al., 2010). Accumulation of scientific 
evidence points to the fact that nonadherence to prescribed medication is responsible for 
the numerous diabetic complications that have become prevalent among diabetic patients 
(Remington et al., 2010; Kumar et al., 2010). Results from empirical studies have shown 
that adherence to recommended antidiabetic drugs helps to achieve tight glycemic 
control. Adherence to antidiabetic medications also helps to decrease systemic, 
glomerular hypertension, inflammatory process and prevents metabolic syndrome 
(Kumar et al., 2010; Papadakis et al., 2015). In this quantitative study, I examined the 
predictive relationships between adherence to medical treatment for diabetes, HbA1c 
levels and diabetic complications among diabetics in Jamaica. I used the cross-sectional 
design for this study. The data was collected at one point, hence the time is fixed and 
considered the hallmark of this study design (Creswell, 2014).  
22 
 
In chapter 2, I will review current literature on nonadherence to antidiabetic 
medications and diabetic complications. Findings from studies have revealed that 
nonadherence to antidiabetic medications may be associated with various diabetic 
complications. I will start the chapter with a preface of nonadherence to antidiabetic 
medications and progress to literature search strategy, theoretical foundation and 




Chapter 2: Literature Review 
Introduction 
Patient nonadherence is defined as a patient’s failure to adhere to a prescribed 
course treatment by the attending physician (MedicineNet, 2018). Nonadherence to 
physician prescribed antidiabetic medication is a complex and multidimensional problem 
(Hugtenburg et al., 2013). According to Hugtenburg et al. (2013), diabetic patient 
nonadherence to treatment can consist of any of the following actions: (a) patient refusal 
to fill or refill medication prescriptions in a timely manner which results in failure to 
commence treatment or a gap during the period of treatment, (b) patient using more 
medications or less medications than what is prescribed by a physician, and (c) patient 
deviating from the doctor prescribed schedule for taking medications. Irrespective of the 
reason for patient nonadherence, a major consequence of nonadherence is that the 
individual will not be able to obtain an optimal pharmacotherapeutic benefit; 
consequently, the individual faces increased diabetic complications (Hugtenburg, 2013).  
Studies have shown that antidiabetic medications are essential in preventing the 
complications of diabetes mellitus (Blackburn, Swidrovich & Lemstra, 2013; 
Hugtenburg, 2013). Diabetic complications associated with medication nonadherence 
have been attributed to increased mortality among people with diabetes and have caused 
unbearable healthcare cost burdens to many countries (Blackburn et al., 2013). 
Nonadherence to antidiabetic medication is a serious public health challenge and has 
become a priority for governments and healthcare providers around the globe. According 
to Blackburn et al. (2013), factors such as concurrent chronic use of multiple medications 
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to treat numerous comorbidities, advancing age, socioeconomic factors, gender, and even 
fear of side effects of antidiabetic medications all contribute to nonadherence. 
Nonadherence to medication among diabetic patients is high and even alarming when 
compared to other conditions, and it is inextricably linked to multiple hospitalizations and 
diabetic complications (Blackburn et al., 2013).  
The purpose of this study was to explore any correlations between nonadherence 
(low levels of adherence and high levels of HbA1c) and diabetic complications 
(cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and neuropathic 
diabetic foot ulcers). In this chapter I will cover the strategies that I used in the search of 
literature, the theoretical foundation, and the framework of this study. I will also review 
related current literature on the association of nonadherence to antidiabetic medication 
with cardiovascular diseases, diabetic retinopathy, diabetic nephropathy, and diabetic 
neuropathic foot ulcer.  
Literature Search Strategy 
I conducted an extensive search of relevant literature digitally through electronic 
medical and public health databases such as MEDLINE, CINAHL, American Diabetes 
Association (ADA), Medscape, Univadis, New England Journal of Medicine as well as 
through Walden University library database. I used search terms such as diabetes mellitus 
Type 1, diabetes mellitus Type 2, diabetic complications, retinopathy, nephropathy, 
cardiomyopathy, and diabetic foot to conduct the literature search. I obtained other 
sources and articles for this literature review traditionally through printed versions of 
professional journals such as the Journal of American Pathologists, as well as numerous 
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medical books on pathologic basis of disease, public health epidemiology and 
environmental health. All books, journals, and electronic print materials used in this 
study were published within the last 6 to 7 years. 
Theoretical Foundation  
I used the theory of planned behavior as the theoretical framework for this study. 
According to Ajzen (1985), the theory of planned behavior explicates that human actions 
are guided by three major considerations which include: a) beliefs regarding the likely 
outcomes of a behavior and the evaluations of the belief’s outcomes; b) normative 
beliefs, which are expectations of others and motivation to conform with these 
expectations; and c) control beliefs, which states that the presence of influencing factors 
may enable or hinder manifestation of a behavior. When attitude towards behavior is 
combined with subjective norm coupled with perception of behavioral control, it results 
in the development of a behavioral intention (Rich, Brandes, Mullan, & Hagger, 2015). 
The theory of planned behavior has proven to be useful in predicting behavior such as 
adherence. Levels of adherence could be predicted based on consistent forms of attitude, 
subjective norm, perceived behavioral control, intention and previous behaviors (Rich et 
al., 2015).  
According to Van Camp et al. (2016), planned behavior could potentiate 
satisfactory or unsatisfactory behaviors, good or bad intentions, positive life-changing 
attitudes, or negative self-destructive attitudes that could translate to variance in actions. 
According to Sharma and Romas (2012), studies have shown that people seem to 
consider the implications of their action before engaging or refraining from various kinds 
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of behaviors. Nonadherent behaviors could be predicted with a high degree of accuracy 
by closely examining patient’s attitudes toward medical treatment, their perceived 
behavioral control and subjective norms. When a patient has a sufficient behavioral 
control coupled with good intentions the patient is most likely go to adhere to treatment 
regime (Sharma & Romas, 2012).  
Literature Review Related to Key Variables 
Diabetes mellitus (DM) 
DM is defined as a chronic metabolic syndrome that is characterized by 
hyperglycemia, hyperlipidemia, and elevated amino acids (Kumar et al., 2010). Kaul, 
Tarr, Ahmad, and Chibber (2013) suggested that diabetes mellitus is a chronic 
debilitating metabolic disease that has tremendous health consequences. Diabetes 
mellitus compromises the immune system, promotes retinopathy, nephropathy, 
neuropathy (somatic and autonomic), and cardiovascular diseases. Khardori et al. (2015) 
defined diabetes mellitus as chronic metabolic disorder that has been classified as Type 1 
and Type 2. According to Khardori et al. (2015), Type 1 diabetes mellitus is a chronic 
disease that affects multiple organs and the nervous system. Type 1 diabetes affects the 
metabolism of carbohydrate, fat, and protein due to the absence of insulin caused by 
autoimmune destruction of the beta cells which translates to metabolic catastrophe unless 
it is adequately managed. Type 1 diabetes mellitus can occur at any age, but it is more 
common among juveniles; however, adults in their late 30s and early 40s have been 
diagnosed of Type 1 diabetes mellitus. 
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Type 2 diabetes is characterized by a combination of insulin resistance at the 
peripheral level and inadequate insulin secretion by the beta cells in the pancreas. 
According to Khardori et al. (2015) insulin resistance is a major complication of 
sustained elevated levels of free fatty acids and pro-inflammatory cytokines in the 
plasma, which decreases glucose transport into muscle cells and results in elevated 
hepatic glucose production. Patients living with Type 2 DM do not unequivocally depend 
on insulin for life; however, they may need insulin as the disease progresses and or when 
the pancreas completely fails to secret insulin (Kumar et al., 2010).  
Type 2 diabetes mellitus was originally considered adult-onset diabetes but 
findings from studies have shown that the epidemic of obesity coupled with sedentariness 
among children in certain populations has resulted in Type 2 DM (CDC, 2016; Kumar et 
al., 2010). However, individuals who are 40 years and older who have a family history of 
DM are at greater risk for Type 2 DM (ADA, 2016). Empirical data show that Type 2 
diabetes increases the risk of coronary heart disease (CHD) in women more than in men 
(ADA, 2016). 
Papadakis and McPhee (2015) maintained that diabetes mellitus is a metabolic 
syndrome that is characterized by hyperglycemia due to malfunction of the pancreatic 
islet cells that translates to paucities of insulin secretion and or insulin resistance. Kumar 
et al. (2010) argued that diabetes mellitus is more than a disease as it presents with a 
group of synchronized metabolic maladies that share a common denominator, which is 
hyperglycemia. Results from studies have shown that sustained hyperglycemia translates 
into myriad of organ related complications and even further metabolic dysregulations. 
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Insulin is a metabolic hormone that is essential and indispensable; deficiency or absence 
of insulin secretion that is left untreated or uncontrolled results in various forms of 
diabetic complications. 
Report from Diabetes complications and control Trial (DCCT) revealed that 
 “a near normalization of blood glucose resulted in a delay in the onset of            
diabetes. Data in the same study showed that normalization of blood glucose  
contributed to a major slowing of the progression of established microvascular   
and neuropathic diabetic complications” (p. 1192).  
Results from the study highlights the fact that adhering to recommended 
therapeutics could be successful in preventing diabetic complications (Papadakis et al., 
2015).  
Patient Nonadherence and Diabetic Complications 
According to Chang, Chien, Lin, Chiou, and Chiu (2015) patient nonadherence to 
antidiabetic treatment translates to poor glycemic control which has been associated with 
end-stage renal disease (ESRD) among diabetics. Chang et al. (2015) explored the 
correlations between antidiabetic medication nonadherence and the risk of developing 
ESRD among patients who were newly diagnosed with diabetes mellitus. They extracted 
archived data from the Taiwan National Health Insurance Research Database (NHIRD) 
and identified 559,864 records that met the inclusion criteria for the data analysis. The 
records that met the criteria for the study belonged to individuals between the ages of 20 
to 85 years during the study. Chang et al. (2015) indicated that records show that 16695 
patients developed end stage renal disease (ESRD) during the 6-year study period. The 
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researchers found that patients who did not adhere to antidiabetic medication therapy had 
higher risk of developing ESRD when compared to patients who adhered to antidiabetic 
medication therapy. The outcome of the study also revealed that adherence to antidiabetic 
medication could prevent the acceleration of the loss of renal function and even ESRD 
among diabetic patients. 
According to Busko (2014), nonadherence to antidiabetic medication results in 
sustained hyperglycemia which has long term effect on the microvasculature and most 
major organs. Living with either Type 1 or Type 2 diabetes for more than 10 years has 
been associated with microvascular and macrovascular complications such as 
cardiomyopathies, nephropathy, or even retinopathies. These recent findings provide a 
unique opportunity to health care providers to refocus efforts towards intense or 
aggressive management of hyperglycemia from the time of diagnosis of diabetes among 
younger population to minimize the risk of long-term complications. 
Variables Related to Adherence to Medication 
Kirkman et al. (2015) conducted a retrospective study analysis of records obtained 
from a pharmacy claims database examining patients, types of medication, and their 
prescribers to determine a range of factors that may have influenced adherence to the 
prescribed antidiabetic medications. They analyzed more than 200,000 patients records of 
individuals who received treatment for diabetes mellitus with oral antidiabetic 
medications in 2010 (Kirkman, 2015). The outcome of the study revealed that adherence 
to medication was correlated with older age, being a man, higher levels of education, 
higher income, method of delivery of medication, and lower copay for medications. Data 
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from the study showed that newly diagnosed diabetic patients perceived to be healthy 
with no comorbid conditions and who were taking few medications were at greater risk 
for nonadherence to antidiabetic medication than the older population with multiple 
comorbid conditions (Kirkman, 2015).  
In a secondary data analysis of medical records and questionnaires obtained from 
1369 diabetic patients, Billimek et al. (2014) found that gender disparities in 
nonadherence to medications was responsible for differences observed in lipid 
management among individuals living with Type 2 diabetes mellitus. The outcome of the 
same study also indicated that the level of nonadherence among women living with 
diabetes was associated with the side effects of the medications in question, in addition to 
the cost of the medication. They concluded that even though the quality of diabetic care 
given to both men and women was comparable, women living with diabetes presented 
with poor lipid control more frequently than men living with diabetes mellitus (Billimek 
et al., 2014).  
Busko (2014) suggested that patients who are diagnosed with Type 2 DM at a 
relatively younger ages were more susceptible to diabetic complications as they get older, 
due to nonadherence over time. Busko (2014) also suggested that older patients living 
with Type 2 diabetes for a longer time coupled with nonadherence have shown to be at an 
increased risk of having cardiovascular events such as cardiovascular myopathies, fatal or 
nonfatal myocardial infarction, or fatal or nonfatal stroke. 
Rosengren et al. (2015) conducted a cohort study involving 33402 participants 
who had DM for an average of 20 years and were followed for about 8 years. The 
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outcome of the study revealed that the percentage of participants admitted to the hospital 
due to heart failure increased as their age and the duration of diabetes increased. Findings 
from the study also showed that uncontrolled hyperglycemia increased the risk of heart 
failure and albuminuria among the population. In addition, the study revealed that 
participants that had Type 1 diabetes had a four times increased risk of being hospitalized 
due to heart failure, when compared with the general population.  
Khardori et al. (2015) argued that cardiovascular myopathies among people living 
with diabetes is common because it is related in part to nonadherence to antidiabetic 
medication which promotes elevated levels of low-density lipoprotein (LDL), low levels 
of high-density lipoprotein (HDL), high levels of triglyceride-rich remnant lipoproteins, 
thrombotic abnormalities such as high levels of type-1 plasminogen activator inhibitor 
(PAI-1), and elevated levels of fibrinogen. 
There are obvious disparities in the burden of DM among various populations in 
the United States and the world. According to the CDC (2016), African Americans and 
Hispanic Americans have been disproportionately affected by diabetes mellitus more so 
than any other group in the United States. According to Ogden, Carroll, Kit, and Flegal 
(2013) data from the National Health and Nutrition Examination Survey from 2011–2012 
show that more than one-third (34.9%) of American adults were obese in 2011–2012. 
The survey also showed that obesity was higher among middle-aged adults (39.5%) than 
among younger (30.3%) or older (35.4%) adults. There were no disparities between men 
and women during same period. However, overall among non-Hispanic Black adults, 
56.6% of women were obese compared with 37.1% of men (Ogden et al. 2013). Obesity 
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in the United States was more prevalent among non-Hispanic Black (47.8%) followed by 
Hispanic (42.5%), non-Hispanic white (32.6%) and less prevalent among non-Hispanic 
Asian adults (10.8%) (Ogden et al., 2013). Studies have shown that obesity or being 
overweight is a major reason for the alarming prevalence of Type 2 diabetes (WebMD, 
2016).  
Risk Factors 
The risk factors for Type 1 DM include family history (mother, father, or sibling) 
with Type 1 diabetes, being of Northern European ancestry, genetic factors such as 
positive human leucocyte antigen (HLA-DR3, DR4 and DQ), and environmental factors 
(WebMD, 2016; Medscape, 2018). The risk factors for Type 2 diabetes include first 
degree relative with DM, obesity or being overweight, impaired glucose tolerance, insulin 
resistance, race (African American, Hispanic, and American Indian). Polygenic 
components such as high blood pressure, low levels of high-density lipoprotein (HDL), 
and high levels of triglycerides, gestational diabetes, sedentary lifestyle, polycystic ovary 
syndrome, and advancing age greater than 45 years increases the risk of Type 2 DM 
(WebMD, 2016; Medscape, 2018). 
According to the Dunn et al. (2014) autoimmune reaction triggered by an 
infection such as Coxsackie B virus in a genetically susceptible individual is related to 
the etiology of Type 1 diabetes mellitus. The pathogenesis involves lymphocytic 
inflammation of the islet of Langerhans (insulitis) that leads to loss of B-cells and fibrosis 
of the islets (Kumar et al., 2010). Subsequently, defects in the translation of the insulin 
RNA occurs in the ribosomes attached to the rough endoplasmic reticulum (RER). The 
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RER is the location where insulin preprohormone is formed. The insulin preprohormone 
are subsequently cleaved to produce proinsulin which are further cleaved in the Golgi 
apparatus producing insulin and peptide fragments. Inability to synthesize insulin is a 
classical pathology associated with Type 1 DM. Insulin synthesis abnormality seen in 
Type 1 DM has been associated to genetic abnormality and exposure to environmental 
factors such as early childhood infection (Dunn, et al., 2014). 
Studies have shown that being overweight or obesity is a risk factor for Type 2 
DM because such individuals may have increased insulin resistance (Kumar et al., 2010; 
Remington et al., 2010; Khardori et al., 2015). Obesity or being overweight adds an 
undue stress to the beta cells of the pancreas. Obese individuals eat more to meet their 
bodies energy demands, and overeating stresses the membranous network in the cells 
particularly endoplasmic reticulum. Results obtained from studies have shown that when 
the endoplasmic reticulum has metabolic product overload it sends a negative feedback, 
signaling the cell to dampen the insulin receptors on the cell surface. Sustained 
dampening of the insulin receptors due to persistent hyperglycemia translates in to insulin 
resistance (Medicinenet, 2018). Type 2 DM develops only in individuals who cannot 
adequately compensate for their insulin demand due to their insulin resistance; their 
insulin concentration is usually elevated, yet inadequate for tight glycemic control 
(Kaplan et al., 2017). Sedentary behaviors and elevated body mass index (BMI) increase 
the risks of diabetes, and other chronic diseases (Remington et al., 2010). According to 
the WHO (2018) a sedentary lifestyle increases the risk of cardiovascular diseases, 
diabetes, and obesity. When physical inactivity combines with nonadherence to 
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prescribed antidiabetic medications, the synergistic effect accelerates diabetic 
complication among diabetics (Medscape, 2018). Rosengren et al. (2015) suggested that 
inadequate glycemic control coupled with sedentary behavior tremendously increased the 
risk of cardiac abnormalities among diabetics.  
Nonadherence to Medications Among Jamaicans 
Result from the 2007/8 Jamaica Health and Life Style Survey (JHLS) of 
individuals between the age of 15 to 74 years of age, revealed that about 7.9% of the 
population of were living with DM, while 2.8% had impaired fasting glucose also known 
as prediabetes (Ferguson et al., 2010). The same study elucidates that comorbid 
conditions were common among the target population. About 10.7% of the diabetic 
population reported they had one comorbid condition, with 22.3% reporting two 
comorbid conditions, while 63.2% reported that they had three or more comorbid 
conditions. Only 3.8% of the diabetics reported no comorbid conditions (Wilks et al., 
2009). In addition, data from the survey showed that only 43.9% of diabetics in Jamaica 
had tight glycemic control, while 52.6% reported uncontrolled diabetes. This finding 
highlights an alarming prevalence of nonadherence to antidiabetic treatment in Jamaica. 
Wilks et al. (2009) also reported that results from the 2007/8 JHLS revealed that only 
40% of diabetics in Jamaica adhered to their antidiabetic medication, while 60% were 
non-adherent.  
Common reasons for nonadherence among this target population included 
inability to afford medication (7%), sense of feeling better (3.3%), side effects of the 
medications (3.0%), hearing other people complain of side effects (1.4%), forgetfulness 
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(11%), individuals running out of medication before next appointment (9.0%), and some 
diabetics could not bother taking the medications as prescribed (7.0%) (Wilks et al., 
2009). The epidemiology of nonadherence to antidiabetic medication is real and the 
alarming incidence of diabetic complications among this target population seem to 
correlate with the level of nonadherence to antidiabetic medication therapy.  
According to 2007/8 Jamaica Health and Life Style Survey (JHLS) interventions 
to prevent nonadherence to antidiabetic medications should be tailored to the specific 
needs of each patient since it is obvious that there are different causes of nonadherence 
(Hugtenburg, 2013). Preventive measures implemented at the primary level, secondary 
level, and tertiary level coupled with many factors working synergistically may be the 
antidote to combat nonadherence to antidiabetic medications that translates into diabetic 
complications (ADA, 2016). It is a known fact that lack of access to good quality 
healthcare may be partly responsible for the alarming rate of nonadherence to antidiabetic 
medications in resource poor countries like Jamaica (Rosennberg, 2011). Hence, if the 
government of Jamaica is serious about reducing diabetic complications, they must 
guarantee access to a well-funded healthcare system for all its citizens.  
According to the Ministry of Health (2015) the Jamaican government guarantees 
access to public hospitals for all its citizens. However, the healthcare system is grossly 
underfunded and severely underserved, hence best medical practices are constantly in 
jeopardy. The long wait time discourages patients from attending scheduled visits, and as 
a result, many patients run out of antidiabetic medications. Some diabetics stay home, 
and only seek care when they start experiencing severe complications (The Jamaican 
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Gleaner, 2014). Addressing the challenges that diabetics face while trying to access the 
healthcare system is an important preventive measure that cannot be over stated.     
Adverse Outcome of Nonadherence to Treatment for Diabetes  
Living with either Type 1 or Type 2 diabetes for more than 10 years has been 
associated with microvascular and macrovascular complications such as 
cardiomyopathies, nephropathy, retinopathies and neuropathic foot ulcer (Busko, 2014). 
Atrophy of the pancreas is a diabetic complication that develops because of prolonged 
and uncontrolled hyperglycemic state (Kumar et al., 2010).  
Cardiovascular Disease 
Rosengren et al. (2015) conducted a cohort study with 33,402 participants to 
determine the effect of uncontrolled hyperglycemia. The mean age of the patients was 35 
years with standard deviation (SD) of 14. 45 years. The participants had diabetes for an 
average of 20.1 years [SD 14·5]). The researchers followed participants for about 8 years. 
They found that uncontrolled hyperglycemic state translated into increased risk of heart 
failure and albuminuria for diabetic patients. Result from the study show that 1062 (3%) 
of the participants were admitted to the hospital following heart failure. The percentage 
of heart failure increased as the patient advanced in age, and as the duration of diabetes 
increased. Participants with Type 1 diabetes had four times increase in the risk of being 
hospitalized due to heart failure, when compared with the general population. 
Papadakis et al. (2015) argued that cardiovascular myopathies among people 
living with diabetes has being associated to insulin resistance or lack of insulin synthesis. 
Khardori et al. (2015) indicates that the dysfunction of insulin or lack of insulin synthesis 
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coupled with nonadherence to medical treatment amplifies low-density lipoprotein 
(LDL), triglyceride-rich remnant lipoproteins, type-1 plasminogen activator inhibitor 
(PAI-1), fibrinogen and suppresses high-density lipoprotein (HDL). Khardori et al. 
(2015) also reported that microvascular and macrovascular DM complications include 
cardiovascular disease, which occurs subsequent to concomitant lipid abnormalities such 
as elevated levels of low-density lipoprotein (LDL), decreased levels of high-density 
lipoprotein (HDL) and high levels of triglyceride. There are also thrombotic 
complications such as high type-1 plasminogen activator inhibitor (PAI-1) and elevated 
fibrinogen. 
Diabetic Retinopathy 
There are two categories of diabetic retinopathy: proliferative and 
nonproliferative retinopathies. The nonproliferative retinopathy is the early stage of the 
retina involvement and it is characterized by the presence of microaneurysms, dot 
hemorrhages, exudates and retinal edema in-addition to macular edema. During the 
nonproliferative stage, the integrity of retinal capillaries is compromised resulting in 
leaking of proteins, lipids, and red blood cells into the retina. When macular edema 
occurs, the functionalities of the visual cells are hampered resulting in the interference 
with visual acuity, hence visual impairment. Proliferative retinopathy is more common in 
Type 1 diabetes mellitus than Type 2 and involves the growth of new capillaries within 
the retina. Proliferative retinopathy develops due to prolonged small vessel occlusion that 




Diabetic nephropathy is caused by persistent hyperglycemia that cause 
hyperfiltration, glycation of metabolites, activation of cytokines, and subsequent renal 
injury (Medscape, 2017). Diabetic nephropathy presents like an autoimmune disorder that 
has an overlapping pathophysiology of innate immunity and regulatory T-cells activities 
in both Type 1 and Type 2 diabetes (Medscape, 2017; Papadakis et al., 2015). Elevated 
blood glucose and saturated fatty acids levels create an inflammatory medium, which 
results in activation of the innate immune system, thereby activating the nuclear 
transcription factors-kappa B (NF-κB), and subsequent release of inflammatory mediators 
such as interleukin (IL)–1β and tumor necrosis factor (TNF)–α. This promotes systemic 
insulin resistance and β-cell damage due to autoimmune insulitis. Elevated serum glucose 
and free fatty acids levels, and IL-1 causes glucotoxicity, lipotoxicity, and IL-1 toxicity, 
which culminates in apoptotic β-cell death. Hyperglycemia increases the expression of 
transforming growth factor-β (TGF-β) in the glomeruli and of matrix proteins, that are 
directly stimulated by this cytokine. TGF-β and vascular endothelial growth factor 
(VEGF) are likely to be instrumental in cellular hypertrophy and enhanced collagen 
synthesis, thereby inducing the vascular often displayed in diabetic nephropathy 
(Medscape, 2017). 
Diabetic Neuropathic Foot Ulcer 
Diabetic neuropathic foot ulcer is common among diabetic patients with 
prolonged duration. According to WebMD (2017) diabetes coupled with nonadherence 
increases the risk for neuropathy, and foot ulcer. Lack of tight glycemic control triggers 
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an axonal neuropathic process that damage vulnerable nerves particularly the long nerves 
Diabetic neuropathy diminishes protective sensation and muscle coordination in the 
lower extremities due to denervation of the small muscles of the foot. Diabetic 
neuropathic foot ulcers occur due to some mechanical changes in bony conformation 
hence altering the architecture of the foot, peripheral neuropathy, and peripheral arterial 
disease (Papadakis et al. 2015).  
Previous Studies Using the Proposed Methodology 
Nonadherence to medical treatment is a problem that has gained enormous 
attention. Researchers worldwide have done extensive studies to identify the cause of the 
problem and to find solution to nonadherence. Quilliam, Ozbay, Sill and Kogut (2013) 
used secondary data obtained from Medstat MarketScan database to measure the 
association between adherence to oral antidiabetic drugs and hypoglycemia in persons 
with Type 2 diabetes. Medstat MarketScan collected their data through a cross sectional 
correlational study design. The investigators included inpatient and outpatient medical 
visits records, pharmacy claims records, and patient eligibility files from 2004 to 2008. 
The MarketScan database captured all relevant healthcare information, both inpatient and 
outpatient, including medical visits and pharmacy claims.  
Quilliam et al. (2013) conducted a retrospective study using a new user design 
record to quantify the association between patient adherence to metformin, sulphonylurea 
or thiazolidinedione, and the incidence of hypoglycemic events during the same period. 
The researchers identified Type 2 diabetics as their target population, and specifically 
those managed on metformin, sulphonylurea or thiazolidinedione. They established the 
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following inclusion criteria: the patient must be at least 18 years of age, have had two 
claims with a Type 2 diabetes diagnosis confirmed by The International Classification of 
Diseases (ICD-9) code 250.X, 250.X0 or 250.X2, or have had at least one pharmacy 
claim for metformin, a sulphonylurea or a thiazolidinedione. The difference between the 
study conducted by Quilliam et al. (2013) and my proposal is that I will be exploring 
correlations between patient adherence to antidiabetic medication and diabetic 
complications, while Quilliam et al. (2013) examined the association of antidiabetic 
medications with a major side effect, which is hypoglycemia. 
Summary and Conclusion 
Studies have shown that tight glucose control reduces diabetic complications 
among people with diabetes (Shivashankar et al., 2016; Medscape, 2017). The American 
Diabetes Association (ADA) clinical practice guideline presents sufficient evidence that 
supports the need for tight glycemic control (ADA, 2016). Diabetes mellitus is a chronic 
metabolic disorder that has become global epidemics with enormous social, health, and 
economic implications (Shivashankar et al., 2016). The National Diabetes Statistics 
report revealed that in 2014, 29.1 million individuals or 9.3% of the American population 
were living with diabetes mellitus. The same report suggested that only 21 million of 
those living with diabetes were diagnosed, while about 8.1 million people were 
undiagnosed (CDC, 2016). WHO (2016) statistical evidence suggested that in 2014 an 
estimated 422 million people worldwide were living with diabetes mellitus. It is 
anticipated that in the next couple of years, the prevalence rate of diabetes mellitus will 
increase to about 530 million if adequate preventive measures and better control or cure 
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is not in place. Empirical data had shown that about 50% of the putative diabetics are not 
diagnosed until 10 years after onset of the disease or when some diabetic complications 
such as retinopathy, diabetic nephropathy or cardiovascular diseases have started 
manifesting.  
In this quantitative study, I explored whether there were any predictive 
relationships between patient adherence to medication for diabetes and severity of 
diabetic complications among diabetics in Jamaica. I will use the cross-sectional design 
for this study. For this quantitative, correlational study I used data obtained from both in 
and out patients who had been diagnosed with either Type 1 or Type 2 diabetes mellitus 
in public hospital and private clinics in Jamaica. In chapter 3 I will describe the research 
method, purpose of study, research design and rationale, target population, sampling and 
sample procedure, procedure used for collection of archived data, procedure I used to 
access archived data, instrumentation and operationalization of constructs, ethical 




Chapter 3: Research Method 
Introduction  
The purpose of this study was to explore the predictive relationships between 
patient nonadherence to antidiabetic medication and HbA1C with diabetic retinopathy, 
diabetic nephropathy, cardiovascular diseases, and diabetic neuropathic foot ulcers. In 
this chapter, I will describe the research design and rationale. I will define both the 
independent and dependent variables, identify my research design and its relevance to the 
study and explain time and resource constrains. I will also define my target population, 
sampling, sample size, procedure used for collecting archival data, and data analysis 
using the SPSS. 
Research Designs and Rationale 
In this quantitative study, I explored whether there were predictive relationships 
between adherence to medication for diabetes and HbA1C with diabetic complications 
among people with diabetes in Jamaica. I employed a correlational approach to 
investigate the extent to which levels of adherence to antidiabetic medication corresponds 
with diabetic complication. The correlational study approach is one of the most 
commonly used research designs in health promotion. Creswell (2013) suggested that it 
was also the most appropriate design for this study because no control was required in 
this kind of study. In addition, I used the correlational design because Kellar and Kelvin 
(2013) argued it was useful for predicting the strength and direction of the relationship 
between variables. The correlational study design was appropriate for this study because 
it enabled me to address the link between nonadherence to antidiabetic medication and 
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diabetic complications such as diabetic retinopathy, diabetic nephropathy, cardiovascular 
disease, and diabetic neuropathic foot ulcer. 
Variables   
The independent variables in this study were adherence to recommended 
treatment, which was adherence to antidiabetic medication and HbA1C. Adherence to 
physicians’ prescribed medication refers to the extent to which a patient takes a given 
medication as recommended by a healthcare provider (Ho, Bryson, & Rumsfeld, 2009). 
Adherence was determined by interviewer administered Morisky 8-item Adherence Scale 
questionnaire. The Morisky 8-item Adherence Scale measures levels of adherence from 
0–8 and a patient could score 0 or 1 on each question. A patient was considered adherent 
when he/she had cumulative score of 7 – 8 points or nonadherent when the patient had 
cumulative score of 0 – 6. Another independent variable used in this study was the 
glycated hemoglobin (HbA1C) which Kaplan step2 (2018) refers as a form hemoglobin 
that is measured to determine glycemic control within the last previous months. The 
dependent variables were diabetic complications such as cardiovascular disease, 
retinopathy, nephropathy, and diabetic neuropathic foot ulcers.  
Methodology 
Population Description 
According to Population World (2018), the population of Jamaica in 2017 was 
estimated to be 2,990,561, with a predominantly Black population at about 92.1%, mixed 
race 6.1%, East Indian 0.8%, other races 1.1%. Approximately 43% of Jamaicans were 
single, 38% were married or in a form of union. About 50% of the population had at least 
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a high school education. Jamaicans who reported they had tertiary level education were 
about 11.3%. About 60% of Jamaicans ages 15-74 years were employed, 45% had full 
time paid employment. The JHLS revealed that 40% of Jamaicans were unemployed 
during the 2008 survey which was the most current survey of that nature done in Jamaica.  
According to Wilks et al. (2008) 33% of Jamaicans have a parent or grandparent 
with diabetes and about half (1/2) of the 33% of population adopted lifestyle changes. 
Private health insurance is not common in Jamaica, only 19% of Jamaicans had private 
health insurance and men were more likely to have the benefit than women. Most 
Jamaicans depend on the free healthcare provided by the government in addition to a 
National Health Fund (NHF) a complementary pharmacy card solely for purchase of 
medications (Wilks et al. 2008).  
Data Collection  
Data were collected from a dataset I obtained from a General Hospital in Jamaica. 
The hospital is in a parish that has a population of 246,322 people and accepts patients 
from all parts of the island. The hospital collected the data by a cross-sectional review of 
patients’ dockets, an interviewer-administered Morisky 8-item Adherence Scale, and 
ICD-9 for chronic disease classifications. Good data quality was ensured by comparing 
responses to questionnaires with medical records. The independent variable-adherence to 
antidiabetic medications, was coded as levels of adherence (0–8), while the second 
independent variable- HbA1c levels, were coded from 1 upwards. Diabetic complications 
such as cardiovascular disease, diabetic neuropathic foot ulcer, diabetic retinopathy, and 
diabetic nephropathy were coded as: 0 = no complication, 1 = moderate complication, 2 = 
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severe complication. Pallant (2010) suggested that the dataset must be checked for error 
within each variable for scores that were not within an acceptable range; identified error 
must be corrected or deleted before proceeding for analysis.   
Sampling and Sampling Procedure 
The records came from individuals who presented at outpatient or inpatient at the 
General Hospital. I used the G*Power analysis to calculate the minimum sample size 
required to detect an effect. The G*Power analysis was used to calculate the optimum 
sample size. The results showed that a total of 111 samples would be needed to have an 
actual power of 0.9503016, Df of 109, critical t of 1.6589535, and noncentrality 
parameter delta of 3.3133098. The effect size | p | is 0.3, alpha error probability is 0.05 
and power (1-beta err probability) of 0.95.  I purposefully selected records from the 
database and the inclusion criteria to include in the data analysis.  
Recruitment, Participation and Data Collection 
The medical records that I used for this study were for individuals who attended 
the public General Hospital as inpatients and outpatients and were diagnosed of diabetes 
mellitus Type 1 or Type 2. These individuals were between the ages 18 years to 95 years 
when they visited the General Hospital between January 2015 to January 2017. The data 
collection was part of the hospital efforts to improve both the intensity and quality of care 
for the patients. The hospital keeps medical records in dockets which is used to review 
patients whenever they return to the hospital. The Morisky 8-item Adherence Scale was 
administered to people with diabetes who visited the hospital for treatment and chose to 
participate. The questionnaires were read out to patients who could not read or who 
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needed assistance for clarity and understanding of the questions. The hospital also offered 
HbA1c test to the patients as part of the data collection and to determine glycemic control 
within the previous 3 months. 
Validity and reliability of data collection and record keeping  
In a quantitative study, the researcher must be concerned with the accuracy and 
validity of the data collection techniques. Content validity refers to the degree to which 
an adopted measurement technique includes all the essential questions needed to 
determine the variable of interest, which in this study was the dependent variable of 
medication adherence (Grove & Cipher, 2017). The hospital data collection process 
addressed the concerns regarding the validity and reliability of data collected on patient 
adherence to medication by developing a standard operating procedure (SOP) that 
ensured that only an already validated and standardized instrument would be used in the 
data collection related to the independent variable, which was adherence to medication. 
The hospital used the Morisky 8-item Medication Adherence Scale (MMAS-8) 
questionnaire without any form of modification and it was followed up with HbA1c test 
to determine glycemic control. Junior doctors were trained to administer the MMAS-8 
questionnaires and to score them according to standard procedure. The staff at the 
medical records department were trained to enter the results in the database. Entered data 
are reviewed periodically to ensure that data are accurately entered a junior doctor. The 
General Hospital used this data to improve quality of care for their patients. As a result, I 
assumed that the process and instrument used to collect the data was valid and reliable.  
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Data on the dependent variables were collected through reliable and valid hospital 
machinery. The HbA1c results were computer generated from blood samples sent to the 
hospital laboratory. The instruments the hospital used were adequately calibrated and 
duplicate measures were done to ensure good data quality. The computer-generated 
results were reviewed by a trained medical technologist before the data were entered into 
medical records by the junior doctors. The medical records were periodically reviewed by 
a junior doctor to ensure accuracy of test results. Data on the operational dependent 
variables of retinopathies, nephropathies, cardiovascular diseases, and neuropathic 
diabetic foot ulcers were generated through ICD-9 codes. The ICD-9 codes were 
determined by trained junior doctors who extracted the information from the patients’ 
medical dockets in the hospital and recorded diabetic complications according to severity. 
The data were subsequently entered into the database by trained staff in the medical 
records. Data were reviewed periodically for accuracy by a trained junior doctor. 
Procedure for Gaining Access to Data Set  
I obtained permission from the senior medical officer (SMO) of the hospital, to 
access archived data that was gained for the secondary analysis in this dissertation. I 
received a letter of approval dated October 25, 2017 from the hospital and a copy of 
approval is included in Appendix A. I sorted the data and those essential to study were 
selected. I removed all forms of personal identifiers to ensure that the identity of the 
patients was not compromised. A data set was created from the data obtained, and all the 
variables were entered and defined in SPSS. No historical or legal documents were used 
48 
 
as sources of data; only the archived medical records of individuals from the hospital 
were used to gather data related to the variables of interest for this study.  
Data Analysis Plan 
The focus of my data analysis was to explore associations between independent 
variables (patient adherence and HbA1c levels) and dependent variables (diabetic 
complications). The plan for data analysis involved establishing and testing the null and 
alternative hypothesis and determining the alpha level which is the statistical significance 
level. Assumptions of correlational study designs include: (a) the dependent variables 
must be continuous, interval, or ratio and the independent variables must be continuous 
or dichotomous; (b) the relationship between dependent variable and independent 
variables should be approximately linear; (c) the variables must have a relatively normal 
distribution; (d) there must not be major outliers among the data; (e) for each value of 
independent variables the variance of error terms observed must be constant; and (f) the 
independent variables should not be highly correlated (Kellar & Kelvin, 2013). I 
ascertained that the data met all assumptions of correlational study design. I also 
determined that the variations in the dependent variables is explained by the independent 
variables. Kellar and Kelvin (2013) suggested that another integral part of data analysis 
plan was to determine the relationship between each independent variable and dependent 
variable, and subsequently determine the relative strength of the association of each 
independent variable on the dependent variables.  
I used the SPSS to run multiple regression analyses to test the null hypotheses for 
the research questions. Multiple regression involves the analysis of two or more 
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independent variables. I used this procedure to determine whether the independent 
variables predicted the outcome variables, which was the dependent variables. I used the 
SPSS to perform collinearity diagnostics, homoscedasticity, linearity and normality of all 
the variables. I checked these assumptions by inspecting the normal probability plot (p-p) 
of the standardized residual and scatterplot. According to Pallant (2010) the normal P-P 
plot was used to determine if there were major deviations in normality while the 
scatterplot was used to check for linearity of the model and independent error 
assumption.  
I used the SPSS to run multiple regression analysis that is fundamentally used for 
analyzing multiple dependent and independent variables. Kellar and Kelvin (2013) 
suggested that the beta coefficients provided information regarding predicted changes in 
the outcome with respect to changes in each independent variable when all other factors 
are kept constant.  
Morisky Medication Adherence Scale 
The public hospital used the Morisky 8-item Adherence Scale to collect data on 
the independent variable of adherence to medical treatment.   A self-reported tool that 
was developed by Morisky et al. in 1986, the instrument was termed the Morisky 
Medication Adherence Scale (Mercy Clinic, 2018). The Morisky 8-item Adherence Scale 
has been validated many times and found to have high internal reliability, high 
specificity, and high sensitivity (Okello, Nasasira, Muiru, & Muyingo, 2016). According 
to Morisky, Ang, Krausel-Wood, and Ward (2008) the original instrument, which was 
used to assess adherence to medication for patients with hypertension, had good internal 
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consistency reliability as evidenced by a Cronbach’s alpha equal to .83. The sensitivity or 
accuracy for identifying patients with hypertension of was 93% while the specificity or 
accuracy for identifying individuals without hypertension was 55%. The construct 
validity of the original instrument was supported by results from a confirmatory factor 
analysis, which presented a root mean square error of approximation <0.0101. 
The psychometric properties of the MMAS- 8 have also been investigated in 
several international studies. Cuevas and Penate (2014) validated the psychometric 
properties of MMAS-8 with a Spanish sample. Results from their study revealed that the 
internal consistency reliability, as measured by Cronbach’s alpha was equal to .75. The 
confirmatory factor analysis confirmed on the factor solution showed a GFI of .99, which 
was evidence of construct validity. Okello, Nasasira, Muiru, and Muyingo (2016) also 
tested the psychometric properties of the MMAS-8 with Ugandan a sample and found 
that the internal consistency reliability or Cronbach’s alpha was equal to .65. However, 
their test-retest reliability was low with a weighted kappa equal to 0.36 (95% CI-
0.01,0.73). The overall Kaiser’s measure of sampling adequacy for residuals of 0.72 
supported the construct validity through the factor.  
Scores on the MMAS-8 are assigned based on the patient’s response to eight scale 
questions that is yes or no (Al-Qazaz, Hassali, Shafie, Sulaiman, Sundram, & Morisky, 
2010). Questions 1 to 7 on the Morisky-8 Item Adherence Scale focused on establishing 
whether a patient takes his/her medications as prescribed, and situations that may 
encourage nonadherence to prescribed medications. Responses to questions 1 to 4, and 6 
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were measured as yes, equal to zero (0) point, or no, equal to one (1) point each. Question 
5 response is coded as yes, equal to one (1) point, and no, is equal to zero (0).  
Question 8 was about how often the individuals had difficulty remembering to 
take all their medications as prescribed. Responses to question 8 of the Morisky-8 item 
medication adherence scale include: (a) never or rarely, which equals four (4) points, (b) 
occasionally, which equals three (3) points, (c) sometimes, which equals two (2) points, 
(d) usually, which equals one (1) point, or (e) all the time, which was equal to zero (0) 
point. Total score points from question 8 was divided by 4 to obtain 1 point or a fraction 
of a point. The maximum an individual could score in the Morisky 8-item Adherence 
Scale was 8 points (Plakas et al. 2016). I used this exact scale and psychometrics for this 
study, no changes were made to the data and I analyzed data as collected by the hospital. 
Instrumentation and Operationalization of Variables 
The independent variables in this study were patient adherence to antidiabetic 
medication and HbA1c levels. Adherence to antidiabetic medication was operationally 
defined as consistently taking antidiabetic medications as prescribed by the attending 
physician. The Morisky-8 item questionnaire was administered to the individuals, they 
were required to respond to 8 questions. Each question in the questionnaire was worth 1 
point. The questions were used to determine whether the individuals took their 
antidiabetic medication as recommended by their physicians.  
Nonadherence or adherence was determined by calculating the number of points 
scored by the individual on the Morisky 8-item Adherence Scale. The scores could range 
from 0 – 8. For this study if an individual had a high of level adherence score (7 or 8), 
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that individual is considered adherent and if an individual had a low level of adherence (6 
or less), that individual was considered non-adherent.  
The HbA1c level was measured by immunoassay using the venous blood of the 
individuals. Levels of HbA1c were used to quantitatively determine an individual’s 
glycemic control within the previous 3 months (Papadakis et al., 2015). HbA1c 
measurements of 6.5 and below are considered normal and indicative of tight glycemic 
control. However, measurements above 6.5 are considered abnormal and indicate poor 
glycemic control (Papadakis et al., 2015).  
The operational dependent variables were chronic complications that diabetic 
patients developed over a period. The operational dependent variables include 
retinopathies, nephropathies, cardiovascular diseases, and neuropathic diabetic foot ulcers 
(Abass, Fausto & Kumar, 2010). The severity of diabetic complications was measured 
using the international classification of chronic disease (ICD- 9). The ICD-9 classifies 
chronic conditions from 0 to 2, where 0 = no chronic complication reported, 1 = mild to 
moderate chronic complications and 2 = severe chronic complications.  
Research Questions and Hypotheses 
Research Question 1 (RQ1). How well do patient adherence to antidiabetic 
medication and HbA1c levels predict the severity of cardiovascular disease among people 
with diabetes in Jamaica after controlling for age and gender?  
Null Hypothesis (H01). Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
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severity of cardiovascular disease among people with diabetes in Jamaica after 
controlling for age and gender.  
Alternative Hypothesis (Ha1). Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of cardiovascular disease among people with diabetes in 
Jamaica after controlling for age and gender.  
Research Question 2 (RQ2). How well do patient adherence to antidiabetic 
medication and HbA1c levels (glycemic control) predict the severity of retinopathy 
among people with diabetes in Jamaica after controlling for age and gender?  
Null Hypothesis (H02). Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels (glycemic control) are not statistically 
significant predictors of the severity of retinopathy among people with diabetes patients 
in Jamaica after controlling for age and gender.  
Alternative Hypothesis (Ha2). Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of retinopathy among people with diabetes in Jamaica after 
controlling for age and gender. 
Research Question 3 (RQ3). How well do patient adherence to antidiabetic 
medication and HbA1c levels (glycemic control) predict the severity of nephropathy 
among people with diabetes in Jamaica after controlling for age and gender?  
Null Hypothesis (H03). Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
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severity of nephropathy among people with diabetes in Jamaica after controlling for age 
and gender.  
Alternative Hypothesis (Ha3). Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of nephropathy among people with diabetes in Jamaica after 
controlling for age and gender. 
Research Question 4 (RQ4). How well do patient adherence to antidiabetic 
medication and HbA1c levels predict the severity of neuropathic foot ulcer among 
diabetic patients in Jamaica after controlling for age and gender? 
Null Hypothesis (H04). Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
severity of neuropathic foot ulcer among people with diabetes in Jamaica after controlling 
for age and gender. 
Alternative Hypothesis (Ha4). Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of neuropathic foot ulcer among people with diabetes in 
Jamaica after controlling for age and gender. 
Threats to Validity 
Threats to Internal Validity 
Assessing the internal and external validity helped to ensure that variations 
observed in the dependent variable undoubtedly originate from variations in the 
independent variables and not due to confounding factors (Polit & Beck, 2012). To a 
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great extent, internal and external validity are dependent on how much control has been 
attained in the study while collecting data. The potential threats to internal validity in this 
study included inapt collection of patient history, advancing age, clerical error and recall 
bias (JHLS, 2008). The archived data analyzed were collected through interview 
administered questionnaires and depended on an individuals’ ability to recall events, 
hence recall bias, patient history and clerical error may affect the internal validity of the 
study. These factors that may be threats to internal validity were addressed by comparing 
the information provided in response to the questionnaire with the individual medical 
records. Observed discrepancies between patients’ medical records and responses to 
questionnaire were either corrected, deleted or rejected. 
Threats to external validity 
Diabetics with comorbid conditions take numerous medications that could interact 
with each other. However, it was difficult to test for effects of drug interactions and its 
interference in treatment and hyperglycemic control (Blackburn, Swidrovich & Lemstra, 
2013). The inability to measure and control for variables such as levels of physical 
activity, healthy diet options, effects of smoking on diabetic complications, 
socioeconomic factors, environment and undiagnosed co-morbidities pose threats to  
Validity of the results from this study. All these factors could potentiate the 
development and severity of all diabetic complications (Universal Teacher, 2016). It is 
also essential to mention that a patient’s ability to recall taking medication as prescribed 
by the attending physician and not being honest could be a threat to the validity of result 




Agreement to Gain Access to Data 
Permission to access archived data was received, following request sent to the 
director of non-communicable diseases at the Ministry of Health, Kingston, Jamaica via 
email, and to the Senior Medical Officer (SMO) in the general hospital, Jamaica. Raw 
data contained all patient identifiers, which were cleaned and information relevant to the 
study extracted. Data was coded to eliminate patient identifiers, and risk of exposure, and 
was subsequently analyzed following receipt of approval from both Walden University 
and the general hospital. 
Treatment of Archival Data 
The archived data were safeguarded and will not be divulged to others. Care was 
taken to prevent unwanted access to archived data, as researcher is ethically obligated to 
ensure that the use of the data and or the dissemination of study outcome will not do any 
harm to the system that provided the data, or to the people that accessed the health care 
system. Therefore, archived data were used solely for this study, and if needed for future 
studies, researcher is obligated to notify the hospital system. The data obtained will not 
be shared with any other person or organization. Individual patient informed consents 
were not needed for this study since it was only secondary data analysis. No treatment or 
invasive test done was done during for this study. At the end of this study, archived data 




Chapter 3 outlined description of the study design, sample character and sample 
methods, instrumentation, data analysis and ethical procedures. Rationale was presented 
for using correlational study design instead of other study designs. The data collection 
process used by the hospital system in Jamaica was also described. Adequate 
demographics particularly age and gender which were important for this study were 
obtained from individuals. A cross-sectional patient medical record review was done 
along with interviewer administered Morisky 8-item Adherence Scale used to measure an 
individual’s level of medication adherence and HbA1c measured by ELISA method used 
to determine glycemic control over a 3 months period. The level of adherence and 
glycemic control/HbA1c are the independent variables while diabetic retinopathy, 
diabetic nephropathy, cardiovascular disease, and diabetic neuropathic foot ulcer are the 
dependent variables. A correlational study approach was used to investigate the extent to 
which levels of adherence to antidiabetic medication corresponds with diabetic 
complications. Internal and external validity ensured that variations that were observed 
among dependent variables originated from variations within the independent variables 




Chapter 4: Results 
Introduction 
The purpose of this study was to explore the predictive relationships between 
patient adherence to antidiabetic medications, patient HbA1c levels, and diabetic 
complications among Jamaicans. The general question that guided this research was: 
How well do the independent variables (patient adherence to antidiabetic medication and 
HbA1c levels) predict the severity of diabetic complications (retinopathy, nephropathy, 
cardiovascular disease, and neuropathic foot ulcer) among people with diabetes patients 
in Jamaica after controlling for age and gender? 
Research Question 1 (RQ1). How well do patient adherence to antidiabetic 
medication and HbA1c levels predict the severity of cardiovascular disease among people 
with diabetes in Jamaica after controlling for age and gender?  
Null Hypothesis (H01). Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
severity of cardiovascular disease among people with diabetes in Jamaica after 
controlling for age and gender.  
Alternative Hypothesis (Ha1). Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of cardiovascular disease among people with diabetes in 
Jamaica after controlling for age and gender.  
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Research Question 2 (RQ2). How well do patient adherence to antidiabetic 
medication and HbA1c levels (glycemic control) predict the severity of retinopathy 
among people with diabetes in Jamaica after controlling for age and gender?  
Null Hypothesis (H02). Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels (glycemic control) are not statistically 
significant predictors of the severity of retinopathy among people with diabetes patients 
in Jamaica after controlling for age and gender.  
Alternative Hypothesis (Ha2). Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of retinopathy among people with diabetes in Jamaica after 
controlling for age and gender. 
Research Question 3 (RQ3). How well do patient adherence to antidiabetic 
medication and HbA1c levels (glycemic control) predict the severity of nephropathy 
among people with diabetes in Jamaica after controlling for age and gender?  
Null Hypothesis (H03). Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
severity of nephropathy among people with diabetes in Jamaica after controlling for age 
and gender.  
Alternative Hypothesis (Ha3). Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of nephropathy among people with diabetes in Jamaica after 
controlling for age and gender. 
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Research Question 4 (RQ4). How well do patient adherence to antidiabetic 
medication and HbA1c levels predict the severity of neuropathic foot ulcer among 
diabetic patients in Jamaica after controlling for age and gender? 
Null Hypothesis (H04). Patient adherence to antidiabetic medication (Morisky 8-
item Adherence Scale) and HbA1c levels are not statistically significant predictors of the 
severity of neuropathic foot ulcer among people with diabetes in Jamaica after controlling 
for age and gender. 
Alternative Hypothesis (Ha4). Patient adherence to antidiabetic medication 
(Morisky 8-item Adherence Scale) and HbA1c levels are statistically significant 
predictors of the severity of neuropathic foot ulcer among people with diabetes in 
Jamaica after controlling for age and gender. 
In this chapter I have included information regarding the time frame the hospital 
used for data collection and their recruitment process as well as the response rates. I 
present any discrepancies in data collection or deviations from data collection plan 
presented in the previous chapter. I also present the descriptive and demographic 
characteristics of the sample. It was essential for me to describe if the sample was a true 
representation of the target population or the Jamaican population at large. The data were 
analyzed using multiple regression analysis on SPSS platform. 
Data collection 
The data I used in this study was obtained from a public hospital that has an 
ongoing data collection process for information related to chronic diseases and infectious 
diseases. The archived data used in this study was collected through the Morisky 8-item 
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Adherence Scale questionnaires were issued to patients between January 2015 to 
December 2016 to a total of 119 individuals. These were individuals who visited the 
public hospital within that period and met the participation criteria. The Morisky 8-item 
Adherence Scale and ICD-9 chronic disease classification questionnaire as well as testing 
for HbA1c levels by ELISA method were all administered by trained staff. The 
interviewers were adequately trained and certified by the hospital before they were 
assigned to the patients. Instruments used were adequately calibrated and duplicate 
measures were done according to the standard operating procedure (SOP). 
Results 
Preparing Data for Analysis 
Data cleaning is a major part of data preparation that is done before analysis; two 
types of data cleaning were done before data analysis: the possible code cleaning and 
contingency cleaning. Kellar and Kelvin (2013) argued that possible code cleaning 
involved finding and eliminating errors in the data matrix hence ensuring that only 
answer choices for each question was entered in the associated field. Crossman (2017) 
suggested that during the contingency cleaning I ensured that only those cases that should 
have data on a variable do indeed had such data hence, if a number outside the predefined 
possibilities were entered an error message appeared. I removed all personal identifiers 
from the data set analysis.  
Descriptive statistics 
The independent variables were the level of adherence to antidiabetic medications 
and HbA1c values, the dependent variables included cardiovascular disease, diabetic 
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retinopathy, diabetic nephropathy, and diabetic neuropathic foot ulcer. Table 1 shows 
summary of the descriptive variables for each of the variables included in the data 
analysis. A total of 119 individual medical records were used, of which 42% were male, 
and 58% were female as also shown in Figure 1. 
Levels of adherence to antidiabetic medication was measured with Morisky 8-
item Adherence Scale. The mean adherence level was 6.11 with a standard deviation of 
.35 as shown in Table 1. The chart in Figure 1A reveals that 34.4% of patients had high 
levels of adherence (adherent), and 65.6% had low level of adherence (non-adherent) to 
prescribed diabetic treatment. The HbA1c level was used to determine glycemic control 
within the previous 3 months. The results revealed that the average level of HbA1c was 
8.84, which implied that the overall targeted population did not adequately control their 
glucose levels within the period in question as shown in Table 1. The standard deviation 
of HbA1c levels was 2.83, indicating that some people with diabetes in this target 
population had HbA1c as high as 11.67 while others had HbA1c as low as 6.01. As 
shown in Figure 1B, only 25.2% of the individual had normal HbA1c (4.62 – 6.50) while 
74.8% had abnormal levels of HbA1c (6.60 – 18.03).  
Figure 2 shows that 59.7% of the diabetic population did not report, and were not 
diagnosed with cardiovascular disease, while 15.1% had mild cardiovascular disease, and 
25.2% had severe cardiovascular disease. Data in Table 1 show that the mean for the 
severity of cardiovascular disease was 0.66, with a standard deviation of 0.86 which 
indicated that the frequency of cardiovascular disease among the targeted population was 
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as high as 1.52 in some individuals, while cardiovascular disease was not reported or 
diagnosed in some individuals within the population. 
Figure 2 also shows that 72.3% of the people with diabetes did not have diabetic 
retinopathy, 21% had mild retinopathy while 6.7% had severe diabetic retinopathy. The 
average score for severity of diabetic retinopathy was 0.34 with standard deviation of 
0.603 which also implies that the frequency of diabetic retinopathy among individuals 
was as high as 0.943, while others did not report the disease. Table 1 and figure 3 show 
that 83.2% of the patients were not diagnosed with diabetic nephropathy, 8.4% had mild 
nephropathy while another 8.4% had severe diabetic nephropathy. The mean severity of 
diabetic nephropathy was 0.25 with standard deviation of 0.600 which indicates that the 
frequency nephropathy was as high as 0.85 among some individuals while others did not 
have the disease at all. As shown in Table 1 and Figure 2, 77.3% of the patients were not 
diagnosed with diabetic neuropathic foot ulcer, 9.2% had mild diabetic neuropathic foot 
ulcer while 13.4% had severe diabetic neuropathic foot ulcer. The mean severity of 
diabetic neuropathic foot ulcer was 0.36 with a standard deviation of 0.710 which means 
that the frequency of neuropathic foot ulcer was as high as 0.85 among some people with 
diabetes while some others did not report the complication. 
Table 1 
Summary of Descriptive Statistics of Variables  
Variables                           Frequency        Percent   Mean    Std. Deviation       N 
Gender        Male                                50              42               
                   Female                              69             58                                                   119 
 
Adherence      3-6                                78              65.6        6.11            1.352 




HbA1c Levels    4.62 - 6.50                 25.2          25.2 
(Glycemic cont.) 6.60 – 18.03             74.8          74.8                                               119    
 
No Cardiovascular Disease                 71       59.7         .66                  .858 
Mild Cardiovascular Disease                  18       15.1 
Severe Cardiovascular Disease     30       25.2                                               119 
 
No Retinopathy                             86          72.3         .34                  .603  
Mild Diabetic Retinopathy                 25       21.0                    
Severe Diabetic retinopathy                  8       6.7                                                 119 
 
No Nephropathy                            99       83.2         .25                  .600 
Mild Diabetic Nephropathy                10       8.4 
Severe Diabetic Nephropathy                10       8.4                                                 119 
 
No Neuropathic Foot Ulcer                 92       77.3              .36             .710   
Mild Diabetic Neuropathic Foot Ulcer   11       9.2 




Figure 1A. Bar charts of gender and levels of adherence. 
 
 







Figure 2. Bar chart of Cardiovascular disease and diabetic retinopathy. 
 
Figure 3. Bar chart of diabetic neuropathic foot ulcer and diabetic nephropathy. 
 
 
Testing Statistical Assumptions  
The statistical assumptions of multiple regression include independence of 
variables (adherence level and HbA1c levels) must have a linear relationship with the 
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dependent variables (cardiovascular disease, retinopathy, nephropathy, and neuropathic 
foot ulcer). The residuals must be normally distributed, the independent variables must 
not be highly correlated with each other and the variance of error terms must be similar 
across the values of the independent variables (Kellar & Kelvin, 2013). Figures 4 to 12 
below show scatter plots for each of the independent variables versus diabetic 
complications (dependent variables). The expected cumulative probability of the normal 
p-p plot is on the y-axis while the observed cumulative probability values are on the x-
axis. Normal P-P plot of regression standardized residual suggest that the dependent 
variables are approximately normally distributed for each independent variable.  
I used the scatter plots to check for homoscedasticity, linearity of the model, 
normality and independent error assumption. The plots show a distribution of data that 
are relatively evenly distributed around the zero point. The figures also show that there 
are no major deviations or outliers observed in the randomly displayed data. The scatter 
plot regression standardized residuals are on the y-axis while the regression standardized 
predicted values are on the x-axis. The scatter plots show that the residuals and the 
variance of the residuals are the same for all predicted values. This observation indicates 
that the assumptions of homoscedasticity, linearity of the model and independent error 


































































Inferential statistical analysis  
Using statistical inference, I have made propositions regarding my target 
population, via the data collected from diabetic patients that attended the public hospital 
during the period. I have proposed my hypothesis about the target population from which 
I drew inferences. Multiple regression analysis model was used to generate data that 
inferred statistical properties that included testing hypotheses and descending estimates. 
My targeted population is assumed to be sampled from a larger population (Konishi & 
Kitagawa, 2008). Data analyzed included independent variables (adherence to treatment 
and HbA1c levels) and dependent variables (cardiovascular diseases, diabetic 




RQ1: How well do patient adherence to antidiabetic medication and HbA1c levels 
predict the severity of cardiovascular disease among people with diabetes in Jamaica after 
controlling for age and gender? 
H01: Patient adherence to antidiabetic medication (Morisky 8-item Adherence 
Scale) and HbA1c levels are not statistically significant predictors of the severity of 
cardiovascular disease among people with diabetes in Jamaica after controlling for age 
and gender. 
Ha1: Patient adherence to antidiabetic medication (Morisky 8-item Adherence 
Scale) and HbA1c levels are statistically significant predictors of the severity of 
cardiovascular disease among people with diabetes in Jamaica after controlling for age 
and gender. 
I conducted multiple linear regression analysis to test the null hypothesis for 
Research Question1. Results from the ANOVA test produced results for two regressions 
models. The data revealed that variables in both regression models significantly predicted 
the severity of cardiovascular disease. Model 1 contained age and gender as the 
covariates that were used to test for the effect of interactions of the independent variables 
on the dependent variables (severity of cardiovascular disease) variable, F (2,116) = 
18.26, p = .000. Model 2 contained patient adherence scores and HbA1c levels as 
independent variables, age and gender as covariates, and severity of cardiovascular 






ANOVA Summary Table of cardiovascular disease vs independent variables 
Model                       Sum of  
                                    Squares      Df       Mean Square     F              Sig. 
1 Regression  20.763 2  10.382  18.216 .000b 
 Residual  66.111  116    .570   
 Total              86.874 118    
2 Regression  33.627 4    8.407  17.999 .000c 
 Residual  53.247 114    .467   
 Total              86.874 118    
a. Dependent Variable: Cardiovascular Disease  
b. b. Predictors: (Constant), Age, Gender 
c. c. Predictors: (Constant), Age, Gender, Adherence to treatment, HbA1c levels 
(Glycemic Control) 
The regression model summary is presented in Table 2. Data in this table were 
used to determine how much each variable contributed to the variance in severity of 
cardiovascular disease. Data in Table 3 showed that in Model 1, age accounted for 
20.763% [R2=.24, R2adj=.226, F (2,116) = 18.216, p = .000] of the variance in the severity 
of cardiovascular disease. Adding patient adherence scores and HbA1C levels in Model 2 
resulted in a statistically significant change in the model, R=.622, R2adj=.387, F (2,114) = 
13.771, p = .000] value. Results showed that the R2adj value by increase by .148, which 
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indicated a 14.8% change in the amount of variance accounted for by the regression 
model. Data in table 3 showed that adding patient adherence scores and HbA1C levels 
increased the amount of variance accounted for in the severity of cardiovascular disease 
to 36.6% and 22.6% respectively. Both independent variables made statistically 
significant contributions to the change in variance in cardiovascular disease. 
Table 3.  
Regression Model Summary of cardiovascular disease 
Model    R   R Square   Adj. R   Std. Error                      Change Statistics  
                                      Square           of the   R Square                                    Sig. F     
                                                       Estimate   Change     F Change   df1   df12   Change 
                                                                                                                              
          
1 .489a  .239    .226      .755 .239    18.216 2 116 .000 
2 .622b  .387    .366       .683 .148    13.771 2 114 .000 
 
Beta coefficients were used to determine which variables in the regression model 
predicted the severity of cardiovascular disease. Results for the unstandardized beta 
coefficients in Table 4 showed that only age and HbA1c (glycemic control) were 
statistically significant contributors to the severity of cardiovascular disease. The data 
showed that each unit of change in age resulted in a change of .026 units in the severity 
of cardiovascular disease. Results also revealed that each unit of change in HbA1C levels 
resulted in .114 units of change in the severity of cardiovascular disease. The overall 
regression equation is presented below: 
.203(gender) + .021(age groups) - .022 (patient adherence to treatment) + .114 




Regression Coefficients of cardiovascular disease 
Model                                    Unstandardized Standardized  
                                                   Coefficients                Coefficients            t Sig. 
                                               B Std. Error Beta   
1 (Constant)                       -1.138 .348                         -3.273    .001 
 Gender                        .107 .141              .062             .763    .447 
 Age                                 .026 .004              .481             5.921    .000 
2 
 (Constant)                        -1.837 .698                          -2.632    .010 
 Gender                           .203 .129               .118              1.576    .118 
 Age                                .021 .004               .383               5.047     .000 
 adherence to medication -.022 .063              -.034             -.339       .735 
 Glycemic Control/HbA1c .114 .031              .376              3.700     .000 
 
Diabetic Retinopathy 
RQ2: How well do patient adherence to antidiabetic medication and glycemic 
control/HbA1c levels predict the severity of diabetic retinopathy among diabetic patients 
in Jamaica after controlling for age and gender? 
H20: Patient adherence to antidiabetic medication (Morisky 8-item Adherence 
Scale) and Glycemic control/HbA1c levels are not statistically significant predictors of 
the severity of diabetic retinopathy among diabetic patients in Jamaica after controlling 
for age and gender. 
H2A: Patient adherence to antidiabetic medication (Morisky 8-item Adherence 
Scale) and Glycemic control/HbA1c levels are statistically significant predictors of the 
severity of diabetic retinopathy among diabetic patients in Jamaica after controlling for 
age and gender. 
76 
 
Multiple linear regression analysis was conducted to test the null hypothesis for 
Research Question 2. Result from the ANOVA test produced results for two regressions 
models. The data revealed that variables in both regression models significantly predicted 
the severity of diabetic retinopathy. As shown in table 5 model 1 contained age and 
gender (covariates) as independent variables and the severity of diabetic retinopathy as 
the dependent variable, F (2,116) = 4.937, p = .009. Model 2 contained patient adherence 
scores and glycemic control/HbA1c levels as independent variables, age and gender as 
covariates, and severity of diabetic retinopathy as the dependent variables, F (4,114) = 
3.761, p = .007. 
Table: 5. 
ANOVA Summary Table of Diabetic Retinopathy 
Model                        Sum of  
                                    Squares Df Mean Square           F             Sig. 
 
1 Regression    3.363 2    1.682     4.937 .009b 
 Residual  39.511 116    .341   
 Total              42.874 118    
 
2 Regression    4.998 4    1.250      3.761 .007c 
 Residual    37.875 114    .332   
 Total                42.874 118     
 
a. Dependent Variable: Diabetic Retinopathy 
b. Predictors: (Constant), Age, Gender 
c. Predictors: (Constant), Age, Gender, Adherence or Nonadherence, Glycemic Control 
 
The regression model summary is presented in Table 6. Data in this table were 
used to determine how much each variable contributed to the variance in severity of 
diabetic retinopathy. Data in Table 9 showed that in Model 1, age and gender accounted 
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for 6.3% [R2=.078, R2adj=.063, F(2,116)=4.937, p = .009] of the variance in the severity 
of diabetic retinopathy. When patients’ adherence scores and glycemic/HbA1C levels 
were added in Model 2 they resulted in a statistically significant change in the model, 
R2=.341, R2adj=.086, F(2,114)=2.461, p = .09] value. Result show that the R2adj value 
increased by .038, which indicated a 3.8% change in the amount of variance accounted 
for by the regression model. Data in table 9 showed that adding patient adherence scores 
and glycemic control/HbA1C levels increased significantly the amount of variance 
accounted for in the severity of diabetic retinopathy accounted for by regression model to 
8.6%. 
Table 6. 
Regression Model Summary of Diabetic Retinopathy 
Model    R R Adjusted             Std.                Change Statistics 
                    Square     R Square            of the        R Square    
                                                           Estimate      Change   F Change   df1  df2   Sig. F     
                                                                                                                                Change 
1 .280a .078    .063            .584      .078 4.937       2 116 .009 
 
2 .341b .117    .086           .576      .038 2.461       2 114 .090 
 
Beta coefficients were used to determine which variables in the regression model 
predicted the severity of diabetic retinopathy. Results for the standardized beta 
coefficients in Table 7 showed that only age group was statistically significant 
contributors to the severity of diabetic retinopathy as measured.  The data show that each 
unit of change in age resulted in a change of .009 units in the severity of diabetic 
retinopathy. Both HbA1c and adherence to treatment were statistically insignificant to the 
severity of retinopathy. The overall regression equation is presented below: 
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-.047(gender) + .009(age groups) + .009 (patient adherence to treatment) + .046 
(glycemic control/HbA1C = severity of diabetic retinopathy 
Table 7. 
Regression Coefficients of Diabetic Retinopathy 
Model    Unstandardized              Standardized  
                            Coefficients                           Coefficients 
                                    B    Std. Error         Beta                T         Sig. 
1 (Constant) -.178      .269                    -.662 .509 
 Gender    -.084      .109        -.069        -.776 .439 
 Age       .011      .003          .276          3.091 .002 
2 (Constant) -.586      .589            -.996             .322 
 Gender            -.047      .109             -.039         -.432 .667 
 Age       .009      .003              .228          2.504 .014 
 Adherence  .009      .053               .021           .172 .863 
 HbA1c             .046      .026               .216             1.772 .079  
            Levels 
Dependent variable retinopathy 
 
Diabetic Nephropathy  
RQ3: How well do patient adherence to antidiabetic medication and glycemic 
control/HbA1c levels predict the severity of nephropathy among people with diabetes in 
Jamaica after controlling for age and gender? 
H30: Patient adherence to antidiabetic medication (Morisky 8-item Adherence 
Scale) and Glycemic control/HbA1c levels are not statistically significant predictors of 
the severity of nephropathy among people with diabetes in Jamaica after controlling for 
age and gender. 
H3A: Patient adherence to antidiabetic medication (Morisky 8-item Adherence 
Scale) and HbA1c levels are statistically significant predictors of the severity of 
nephropathy among people with diabetes in Jamaica after controlling for age and gender. 
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The null hypothesis was tested by conducting multiple linear regression analysis 
for Research Question 3. Result from the ANOVA test produced results for two 
regressions models. The data revealed that variables in both regression models 
significantly predicted the severity of diabetic nephropathy. Model 1 contained age and 
gender covariates and the severity of disease diabetic nephropathy as the dependent 
variable, F (3,470) = 5.166, p = .007. Model 2 contained patient adherence scores and 
glycemic control/HbA1c levels as independent variables, age and gender as covariates, 
and severity of diabetic nephropathy as the dependent variables, F (7,871) = 6.490 p = 
.000. 
Table: 8. 
ANOVA Summary Table of diabetic nephropathy 
Model                        Sum of          Df     Mean    F Sig. 
                                    Squares                          Square   
1 Regression    3.470 2      1.735 5.166  .007b 
 Residual    38.697 116      .336   
 Total                42.437 118    
 
2 Regression    7.871 4      1.968 6.490  .000c 
 Residual    34.566 114      .303   
 Total                42.437 118    
a. Dependent Variable: Diabetic Nephropathy 
b. Predictors: (Constant), Age, Gender 
c. Predictors: (Constant), Age, Gender, Adherence or Nonadherence, 
Glycemic Control/HbA1c 
 
The regression model summary is presented in Table 9. Data in this table were 
used to determine how much each variable contributed to the variance in severity of 
diabetic nephropathy. Data in Table 6 showed that in Model 1, age and gender accounted 
for 6.6% [R2=.082, R2adj=.066, F(2,116)=5.166, p = .007] of the variance in the severity 
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of diabetic nephropathy. Adding patient adherence scores and HbA1C levels in Model 2 
resulted in a statistically significant change in the model, R2=.185, R2adj=.157, 
F(2,114)=7.257, p = .001] value. Results show that the R2adj value increased by .104, 
which indicated a 10.4% change in the amount of variance accounted for by the 
regression model. Data in table 6 showed that adding patient adherence scores and 
HbA1C levels increased the amount of variance accounted for in the severity of diabetic 
nephropathy to 15.7%.  
Table 9. 
Regression Model Summary of Diabetic Nephropathy 
 
Model   R   R Square   Adj. R      Std. Error                     __Change Statistics______ 
                                       Square of the  
                                                         Estimate      R Square                                       Sig. F 
                                 Change F Change df1   df12   Change 
          
1 .286a .082    .066            .580       .082 5.166        2    116  .007 
2 .431b .185    .157            .551       .104 7.257        2    114  .001 
 
Beta coefficients were used to determine which variables in the regression model 
predicted the severity of diabetic nephropathy. Results for the standardized beta 
coefficients in Table 10 showed that only age and glycemic control/HbA1C were 
statistically significant contributors to the severity of diabetic nephropathy.  The data 
show that each unit of change in age resulted in a change of .008 units in the severity of 
diabetic nephropathy. Results also revealed that each unit of change in glycemic 
control/HbA1C levels resulted in .086 units of change in the severity of diabetic 
nephropathy. The overall regression equation is presented below: 
81 
 
-.04(gender) + .008(age groups) + .055 (patient adherence to treatment) + .086 
(glycemic control/HbA1C = severity of diabetic nephropathy 
Table 10. 
 Regression Coefficients of Diabetic Nephropathy 
Model              Unstandardized               Standardized  
                            Coefficients                           Coefficients            
                                  B              Std. Error           Beta                 T     Sig. 
1      Constant             -.238           .267                                           -.892                       .374 
        Gender                -.106           .108                     -.088             -.981                        .329 
        Age                    .011              .003                     .278               3.121                      .002  
 2    Constant              -1.262           .562                                          -2.243                     .027   
        Gender                -.040             .104                    -.033              -.382                      .703 
        Age                      .008              .003                   .205                2.349                     .021 
        Adherence level    .055             .051                   .123                1.070                    .287 
        HbA1c /                .086             .025                   .404                 3.449                    .001 
   Glycemic control  
 
Diabetic Neuropathic Foot Ulcer 
RQ4: How well do patients adherence to antidiabetic medication and glycemic 
control/HbA1c levels predict the severity of neuropathic foot ulcer among people with 
diabetes in Jamaica after controlling for age and gender? 
H40: Patient adherence to antidiabetic medication (Morisky 8-item Adherence 
Scale) and Glycemic control/HbA1c levels are not statistically significant predictors of 
the severity of neuropathic foot ulcer among people with diabetes in Jamaica after 
controlling for age and gender.  
H4A: Patient adherence to antidiabetic medication (Morisky 8-item Adherence 
Scale) and glycemic control/HbA1c levels are statistically significant predictors of the 
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severity of neuropathic foot ulcer among people with diabetes in Jamaica after controlling 
for age and gender.  
The null hypothesis for Research Question 4 was tested by conducting multiple 
linear regression analysis. The ANOVA test produced results for two regressions models. 
The data revealed that variables in both regression models significantly predicted the 
severity of diabetic neuropathic foot ulcer. Model 1 contained age and gender 
(covariates) as independent variables and the severity of diabetic neuropathic foot ulcer 
as the dependent variable, F (2,116) = 3.738, p = .027. Model 2 contained patient 
adherence scores and glycemic control/HbA1c levels as independent variables, age and 
gender as covariates, and severity of diabetic neuropathic foot ulcer as the dependent 
variables, F (4,114) = 5.655, p = .000. 
Table: 11. 
ANOVA Summary Table of Diabetic Neuropathic Foot Ulcer 
Model                      Sum of  
                                  Squares          Df           Mean Square           F Sig. 
1 Regression    3.600 2                1.800        3.738      .027b 
 Residual    55.862 116                .482   
 Total                59.462 118    
 
2 Regression    9.845 4                2.461         5.655     .000c 
 Residual    49.618 114                .435   
 Total                59.462 118    
a. Dependent Variable: Diabetic Foot Ulcer 
b. Predictors: (Constant), Age, Gender 





The regression model summary is presented in Table 12. Data in this table were 
used to determine how much each variable contributed to the variance in severity of 
neuropathic foot ulcer. Data in Table 12 showed that in Model 1, age and gender 
accounted for 4.4% [R2=.061, R2adj=.044, F(2,116)=3.738, p = .027] of the variance in 
the severity of diabetic neuropathic foot ulcer. Adding patient adherence scores and 
glycemic control/HbA1C levels in Model 2 resulted in a statistically significant change in 
the model, R2=.105, R2adj=.136, F(2,114)=7.174, p = .001] value. Results show that the 
R2adj value by increase by .105, which indicated a 10.5% change in the amount of 
variance accounted for by the regression model. Data in table 12 also showed that adding 
patient adherence scores and glycemic control/HbA1C levels increased the amount of 
variance accounted for in the severity of diabetic neuropathic foot ulcer to 13.6%.  
Table 12.  
Regression Model Summary Diabetic Neuropathic Foot Ulcer 
                                                                                           Change Statistics 
                                                        Std. Error      R 
                           R          Adjusted    of the        Square        F                                   Sig. F 
Model     Square    R   Square Estimate   Change   Change     df1      df2 change 
1     .246a    .061             .044 .694 .061 3.738      2    116    .027 
2    .407b    .166             .136 .660 .105 7.174        2    114    .001 
 
The beta coefficients were used to determine which variables in the regression 
model predicted the severity of diabetic neuropathic foot ulcer. Results for the 
standardized beta coefficients in Table 12 showed that only glycemic control/HbA1c was 
statistically significant contributor to the severity of diabetic neuropathic foot ulcer after 
controlling for age and gender.  Results in Table 13 revealed that each unit of change in 
84 
 
glycemic control/HbA1C levels resulted in .084 units of change in the severity of diabetic 
neuropathic foot ulcer. The overall regression equation is presented below: 
-.021(gender) + .007(age groups) - .003 (patient adherence to treatment) + .084 
(glycemic control/HbA1C = severity of diabetic neuropathic foot ulcer 
Table 13. 
Regression Coefficients of Neuropathic Foot Ulcer 
 
                                      Unstandardized                    Standardized  
                                        Coefficients                              Coefficients  
Model                           B          Std. Error             Beta               T Sig. 
1 (Constant) -.173                  .320                     -.540 .590 
 Gender            -.091                  .129           -.063         -.701 .484 
 Age               .011                  .004            .242          2.685 .008 
 
2 (Constant) -.777                 . 674                      -1.153 .251 
 Gender            -.021                  .125                        -.015           -.170 .865 
 Age          .007                  .004              .161         1.814 .072 
 Adherence  -.003                   .061               -.005         -.044 .965 
 HbA1c               .084                   .030                .333          2.809 .006 
Dependent Variable: Diabetic neuropathic Foot Ulcer 
 
Summary of Answers to Research Questions 
The independent variables are the HbA1C/glycemic control and adherence levels 
determined by using Morisky 8-item scale while the dependent variables are 
cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and diabetic 
neuropathic foot ulcer. The independent variables HbA1c and adherence levels) 
correlates with cardiovascular disease. Neither HbA1c nor adherence level correlated 
diabetic retinopathy, however, HbA1c correlated with both diabetic nephropathy and 
diabetic foot ulcers after controlling for age and gender. 
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The result indicates that the null hypothesis which suggests that there is no 
statistical predictive relationship between the independent variables (adherence level and 
glycemic control /HbA1c) and the dependent variable (cardiovascular disease, diabetic 
nephropathy and diabetic neuropathic foot ulcer) should be rejected. The P-P plot of 
regression standardized residual were normal suggesting there were no major deviations 
from normality. The scatter plots also show even distribution of data above and below the 
zero axis without obvious outliers.  
In chapter 5, I will present a detailed interpretation of the findings of this study, 
which will be kept within the limits and scope of the study. I will also discuss the 
limitations of this study and the implications for social change. The methodological, 
theoretical, and empirical implications of this study will also be described, and strong 
recommendations and conclusion provided. 
86 
 
Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this quantitative, correlational study was to explore the 
relationship between levels of adherence to antidiabetic medications, HbA1c levels, and 
diabetic complications (cardiovascular disease, diabetic retinopathy, diabetic 
nephropathy, diabetic neuropathic foot ulcer). This study revealed that levels of 
adherence to antidiabetic medication negatively correlates with diabetic complications 
while HbA1c levels positively correlate with diabetic complications.  Nonadherence to 
medications prescribed by a physician is a complex behavioral issue that in most cases 
triggers multidimensional problems. According to Hugtenburg et al. (2013) there are 
numerous factors that are associated with nonadherence. These factors include when a 
patient refuses to fill or refill his/her prescriptions in a timely manner, consequently may 
not commence treatment at all or may not continue treatment as scheduled by the 
attending physician. Nonadherence also includes when a patient uses more prescribed 
medications than directed, less medications than prescribed, or deviates from scheduled 
time of medication administration (Hugtenburg et al., 2013). Results from several studies 
have shown that nonadherence to antidiabetic medications compromises a patient’s 
ability and opportunity to achieve tight glycemic control, hence patients may face acute 
and chronic diabetic complications (Costa et al., 2015; Khan et al., 2012; Kumar et al., 
2010). 
Ferguson, Tulloch-Reid, and Wilks (2010) affirmed that there are only a few 
published studies regarding patient adherence to medication and diabetic complications in 
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Jamaica and the Caribbean region. Hence, I have explored the predictive relationships 
between patient adherence to antidiabetic medications and diabetic complications among 
Jamaicans. It is my expectation that this study will have positive impact among the target 
population and will add to the existing knowledge. Results from empirical studies have 
shown that adherence to antidiabetic medications helps to achieve tight glycemic control, 
reduce systemic and glomerular hypertension, decrease inflammatory processes, and 
prevent metabolic syndrome (Kumar et al., 2010; Papadakis et al., 2015). Common 
diabetic complications observed among the targeted population included: cardiovascular 
diseases, diabetic retinopathy, diabetic nephropathy, and diabetic neuropathic foot ulcers. 
Busko (2014) suggested that patients who are diagnosed with Type 2 diabetes 
mellitus at a relatively young age are more susceptible to diabetic complications as they 
get older. This may be due to the long-term effects of uncontrolled hyperglycemia on the 
microvasculature and organs. According to findings from several studies, tight glucose 
control reduces diabetic complications among people with diabetes (Shivashankar et al., 
2016; Medscape, 2017).  
The result of this study showed that individuals with normal HbA1c (which 
suggested normal glycemic control) within the previous 3 months, had less incidence of 
cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and diabetic 
neuropathic foot ulcers. Nonadherence to medication among diabetic patients is alarming 
(Blackburn et al., 2013). My data analysis showed that a greater number of the 
individuals reported low adherence to treatment which was congruence to their measured 
HbA1c levels.  
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According to UKPDS (2018), it is essential to control glucose levels in order to 
prevent hyperglycemia. Sustained and controlled hyperglycemia seriously damages the 
nerves, blood vessels, and subsequently the major organs. These major organs may 
include: eye (retinopathy), kidney (nephropathy), foot diseases (diabetic foot ulcers) 
increased risk of heart attacks (cardiovascular diseases), and/or strokes. My data analysis 
showed that low levels of adherence to treatment correlates well with cardiovascular 
disease, diabetic retinopathy, diabetic nephropathy and diabetic neuropathic foot ulcer 
after controlling for age and gender.  
Interpretation of the findings 
Age and diabetic complication 
Age was controlled in this study; however, results of this study revealed that age 
consistently correlate with all diabetic complications (cardiovascular disease, retinopathy, 
diabetic nephropathy, and diabetic neuropathic foot ulcers). Data analysis showed that as 
individuals advance in age the severity of diabetic complications increased. Advanced 
aged individuals had more diabetic complications than the younger population. This 
finding may be due to prolonged uncontrolled hyperglycemia.  
Gender and diabetic complication 
Gender was also controlled in this study and results indicated that gender was 
statistically insignificant contributor to change in outcomes observed. The result of my 




HbA1c (glycemic control) and diabetic complication 
Results from numerous studies have shown that nonadherence to antidiabetic 
medications makes the treatment of diabetes difficult and worsens diabetic complications 
(WHO, 2017). According to Fischer (2017), the goal of antidiabetic medication is to keep 
HbA1c within the normal range. The results of this study revealed that high levels of 
HbA1c indicating poor glycemic control increased the severity of all diabetic 
complications (cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and 
diabetic neuropathic foot ulcer). Nearly all the individuals with normal HbA1c were not 
diagnosed and they did not report of any diabetic complications. 
Adherence level and diabetic complication 
According to Wilks et al. (2009), results from the 2007/8 JHLS revealed that only 
40% of diabetics in Jamaica adhered to their antidiabetic medication, while 60% were 
nonadherent. Findings from my study concur with the findings by Wilks et al. (2009). My 
data analysis showed that majority of the people with diabetes reported low level 
adherence (nonadherence) to antidiabetic medication. Most of the nonadherent 
individuals had mild to severe diabetic complications. 
Cardiovascular disease 
The results from the data analysis for this study revealed that abnormally high 
levels of HbA1c were statically significant predictors of low levels of adherence to 
medication prescribed to treat diabetes. The theory of planned behavior has proven to be 
useful in predicting behavior such as adherence. Levels of adherence could be predicted 
based on consistent forms of attitude, subjective norm, perceived behavioral control, 
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intention, and previous behaviors (Rich et al., 2015). The WHO (2010) report states that 
people with diabetes have 2 to 3 times higher rates of cardiovascular disease than the 
general population and nonadherent behavior makes it worse. The results from this study 
revealed that majority of the patients that had experienced sustained uncontrolled 
hyperglycemia had mild to severe cardiovascular disease. This finding supported the 
findings of Amado et al. (2015) who suggested that nonadherence to treatment hinders a 
patient from achieving tight glycemic control, hence making the patient susceptible to 
diabetic complications. The outcome of this study also supported the findings by 
Papadakis et al. (2015), which indicated that cardiovascular myopathy among people 
living with diabetes was related to levels of adherence to treatment for diabetes.  
 Diabetic Retinopathy 
Results from multiple regression analysis of this study revealed that abnormally 
elevated HbA1c levels were statistically significant predictors of the severity of diabetic 
retinopathy. This finding concurred with the finding of Wilks et al. (2009), who reported 
that JHLS revealed that most people with diabetes in Jamaica had diabetic retinopathy 
which was associated with nonadherence to treatment. The severity of diabetic 
retinopathy increased as abnormal HbA1c levels increased indicating poor glycemic 
control. The outcome of my data analysis confirmed the finding of WHO (2010), which 
suggested that the prevalence and severity of diabetic retinopathy among individuals with 
diabetes who have poor glycemic control is high. This finding is also the same as the 
findings of Khaw, Shah, and Elkington (2010), which suggested that diabetic retinopathy 




The findings of this study indicated that HbA1c and levels of adherence to 
treatment had significant predictive relationship with diabetic nephropathy. According to 
Woldu et al. (2014) people with diabetes who poorly control their blood glucose are at 
greater risk of developing diabetic vascular complications that results in end organ 
damage, particularly, the kidney (diabetic nephropathy), heart (cardiomyopathy), and 
eyes (retinopathy). Medscape (2017) indicated that diabetic nephropathy is caused by 
persistent hyperglycemia that leads to renal injury. The findings in this study indicated 
that as abnormally high HbA1c increased, the severity of diabetic nephropathy increased, 
and as level adherence decreased, the severity of diabetic nephropathy increased. These 
findings supported the hypothesis that there is a predictive relationship between poor 
glycemic control (high levels of HbA1c and nonadherence) and diabetic nephropathy. 
The findings of this study confirmed the findings by Chang et al. (2015) that suggested 
that patient nonadherence to antidiabetic medication puts a patient at higher risk of 
developing end-stage renal disease (ESRD) when compared to patients who adhered to 
antidiabetic medication.  
Diabetic Neuropathic Foot Ulcer 
Results obtained from the multiple regression data analysis for this study 
explicated that abnormally high HbA1c levels were statically significant predictors of 
low-level adherence to antidiabetic medications prescribed to treat diabetes.  
The result of data analysis revealed that low level adherence to antidiabetic 
medication was associated with mild to severe diabetic neuropathic foot ulcer. This 
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finding supported the finding of WHO (2017) that suggested that the prevalence of 
diabetic neuropathic foot ulcer is high, and it is directly associated with nonadherence to 
antidiabetic medications. Mayo clinic (2017) also affirmed that diabetic neuropathic foot 
ulcer is a late sequalae of diabetic complication caused by prolonged sustained 
hyperglycemia due to nonadherence to treatment. This study has revealed that HbA1c an 
indicator of poor glycemic control was significant predictor of the severity of diabetic 
neuropathic foot ulcer.  
Limitations of the Study 
The data used for this study were collected at only one general hospital located in 
a small town hence, a limitation to generalization of the outcome to the society at large. 
The level of adherence was self-reported by the patients in response to Morisky-8 item 
medication adherence scale questionnaire, as a result there may be issues regarding 
trustworthiness. However, HbA1c was a significant predictor of level of adherence for 
this study hence resolving questions regarding validity and reliability of the study 
outcome. 
There are other factors that could potentiate complications among people with 
diabetes such as sedentary lifestyle, smoking cigarettes, obesogenic diet options, 
advanced age, late or undiagnosed diabetes mellitus, and the use of complementary or 
alternative medicine (Gemeay et al., 2015; Papadiski, 2015). These possible potentiating 
factors are all beyond the scope of this study and hence were not measured. It is also 
beyond the scope of this study to explore interventions that may enhance adherence 




The results of this study have revealed that low adherence (nonadherence) to 
antidiabetic medication has a significant predictive relationship with diabetic 
complications (cardiovascular disease, diabetic retinopathy, diabetic nephropathy, and 
diabetic neuropathic foot ulcer). Therefore, I recommend further studies on the predictive 
relationship between HbA1c and diabetic complications to expand the body of 
knowledge. It is also important to study how to improve adherence among this targeted 
populations while exploring factors affecting levels of adherence among diabetics in 
Jamaica. In addition, Ferguson, Tulloch-Reid, and Wilks (2010) suggested that there are 
few data addressing nonadherence and diabetic complications in the Caribbean region. 
Hence, I recommend for more extensive studies in this area as such data may be essential 
in planning effective strategies to combat the alarming prevalence of diabetes and its 
complications in the region. 
Implications of the Study 
The implications of this study will be far reaching. Analysis of data from this 
study had shown that low level adherence to antidiabetic medication continues to be a 
significant public health challenge with high burden of diabetic complications.  I expect 
the outcome of this study to have positive effects at the individual level, family level, 
hospital level and could stir up conversations about the benefits of medication adherence 
and the traumatic consequences of nonadherence among the policy makers.  
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Positive Social Change, Theoretical and Empirical Implications 
The potential for positive social change at the individual level, will include an 
adherent behavioral modification that may translate into tight glycemic control as well as 
decreased severity of diabetic complication. The positive impact at the family level, may 
include a healthier, happier and more productive family. At the organizational level, 
diabetics that are adherent to their treatment are less likely to call off sick. Most 
performance rating of healthcare facilities rely heavily on patient medication adherence. 
When patients adhere to treatment plan readmission are reduced to a bearable minimum. 
The outcome of this study has the potential to form the basis for serious 
discussions among policy makers that could result in policies that could lend support to 
diabetics in Jamaica. There are also methodological, and empirical implications of this 
study; the methodology used in this study were already validated and used many times in 
the past. However, the outcome of this study when published will add to few empirical 
data available in the Caribbean region. further scientific investigations in this area, factors 
affecting the prevalence of nonadherence in Jamaica and ways to improve adherence 
among the target population. This study also has the implication for further scientific 
investigations that may broadly exploring factors affecting nonadherence in Jamaica and 
ways to improve adherence among the targeted population. 
As shown in this study, HbA1c is a significant predictor of levels of adherence 
and has strong relationship with diabetic complications. Therefore, I recommend that 
health care providers should find creative ways to get their patients to take their 
medications as prescribed. Health care providers should adopt a shared-responsibility 
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approach; an approach that involves individual patients and their immediate families in 
the plan of care, particularly medication adherence.  
The American Diabetes Association (ADA) has clinical practice guideline 
recommendations regarding the standards of medical care for management of diabetes, 
which are updated regularly based on best available empirical data. Most recently 
updated in 2018, these ADA guidelines are resources that health care providers must 
follow to deliver optimal quality of care for improved patient clinical outcomes. It is true 
that effective management of diabetes that prevents complications is an arduous task 
since it influenced by behavior and complicated by social and economic conditions of the 
patient. It is my recommendation that all these issues be addressed as part of the initial 
plan of care.  
Conclusion 
Diabetes mellitus is a chronic, debilitating metabolic disease that targets multiple 
organs, and has tremendous social and economic consequences. Due to the extensive 
debilitating nature of the disease, there is an obvious expectation on the part of the health 
care providers that patients will take their life and health seriously by taking their 
medications as prescribed. However, when the health seeking behavior of a patient lacks 
congruence with this expectation, there is always colossal traumatic consequences. In this 
research I found that nonadherence to antidiabetic medications has significant predictive 
relationship with diabetic complications. The severity of diabetic complications such as 
cardiovascular diseases, diabetic retinopathy, diabetic nephropathy, and diabetic 
neuropathic foot ulcer increases as abnormally high levels HbA1c increases. 
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Given the outcome of this study, I can suggest that tight glycemic control as 
evidenced by normal HbA1c, decreases the incidence and severity of diabetic 
complications. This finding supports American Diabetes Association’s guideline for 
management of diabetes mellitus in which they recommend that HbA1c levels should be 
controlled at 7.0% or lower in other to prevent diabetic complications. Tight glycemic 
control is achieved only by strict adherence to treatment plan. Adherence to prescribed 
medications coincides with adequate motivation to adapt to lifestyle that integrates 
medication as part of activities of daily living.  
Non-adherent behavior could be predicted according to the theory of planned 
behavior by considering an individual’s beliefs about antidiabetic medications, perceived 
severity of diabetes and its complications, and knowledge about the benefits of adhering 
to antidiabetic medications which outweighs the risk of potential side effects, minor 
discomforts, and even the cost of the medication (Van Camp, Bastiaens, Van Royen, & 
Vermeire, 2016). All health care providers should pay attention to the predictive adherent 
behaviors of their patients and know the best corrective measures to apply in other to 
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